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“With respect to the treatment of this complaint, I have little or nothing to advance (…)   
I knew one who set himself a task of sawing wood for half an hour every day, and was nearly 
cured”. 
 
William Heberden. Some account of a disorder of the breast. 
Medical Transactions 2, 59-67 (1772) London: Royal College of Physicians. 
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Effektar av uthaldstrening på koronar aterosklerose vurdert med gråskala og 
radiofrekvens intravaskulær ultralyd  
 
Aterosklerose i koronararteriene er ei leiande årsak til sjukdom og død. Fysisk inaktivitet er 
ein uavhengig risikofaktor for koronar hjertesjukdom, og det er vist at pasientar som er fysisk 
aktive har bedre prognose enn inaktive pasientar. Sjølv om det er ein klar klinisk samanheng 
mellom fysisk aktivitet og hjertehelse, er mange patofysiologiske effektar av fysisk trening i 
hjertet og kransarteriene ukjende. Dette arbeidet består av tre delstudiar som baserer seg på 
ein randomisert, kontrollert studie av 36 pasientar og ein tverrsnittstudie av 15 pasientar. Alle 
pasientane hadde etablert koronarsjukdom og vart behandla med implantasjon av stent.   
Målet for studie 1 var å undersøke om uthaldstrening kunne føre til fordelaktige endringar i 
koronare plakk, og om det var skilnad mellom intervalltrening med høg intensitet og 
uthaldstrening med moderat intensitet. Gråskala og radiofrekvens intravaskulær ultralyd vart 
brukt til å vurdere studiens endepunkt. Vi fann ein moderat reduksjon av nekrotisk plakkjerne 
og total plakkmengde ved oppfølging, på høvesvis om lag 3 og 10 prosent. Det var ingen 
skilnad mellom dei to treningsgruppene. Desse resultata støttar hypotesen om at 
uthaldstrening påverkar koronar aterosklerose på ein gunstig måte.  
I studie 2 undersøkte vi om kliniske variablar ved studieinklusjon kunne assosierast til 
reduksjon av nekrotisk plakkjerne eller total plakkmengde ved oppfølging. Vi fann ein sterk 
og signifikant assosiasjon mellom den kliniske presentasjonen av koronarsjukdommen og 
nekrotisk plakkjerne volum ved oppfølging. Assosiasjonen var til fordel for pasientar med 
stabil koronarsjukdom samanlikna med ustabilt koronarsyndrom. Resultata frå denne studien 
gir grunnlag for ein hypotese om at dei positive effektane av uthaldstrening på koronare plakk 
kan vere ulik mellom pasientar med stabil koronarsjukdom og ustabilt koronarsyndrom.   
I studie 3 undersøkte vi kor godt samsvar det var mellom to ulike undersøkingar med 
intravaskulær ultralyd i samme pasient på same tidspunkt (reproduserbarheit). Vi fann at det 
var svært godt samsvar mellom undersøkingane i dei delane av arterien som ikkje var stenta 
(relativ skilnad mellom to undersøkingar under 5 prosent), medan det var noko dårlegare 
samsvar mellom undersøkingane i den delen av arterien som var stenta (relativ skilnad 
mellom 5 og 10 prosent). Desse resultata kan får betyding for framtidige studier som brukar 
denne metoden.  
Cand.med. Erik Madssen 
Institutt for sirkulasjon og bildediagnostikk, Det medisinske fakultet, NTNU. 
Rettleiarar: Professor Rune Wiseth og professor Vibeke Videm. 
Finansieringskjelder: Samarbeidsorganet Helse Midt-Norge og NTNU, Forskningsfondet ved 
St. Olavs Hospital, Nasjonalforeningen for folkehelsen/Hjerte-karrådet. 
Overnemnde avhandling er funne verdig til å forsvarast offentleg for graden philosophiae 
doctor (ph.d.)i klinisk medisin. Disputas finn stad i LA21, Laboratoriesenteret, tirsdag 
03.11.15, kl. 12.15. 
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Errata 
 
Paper I 
Text on page 1508 (just below Figure 5)  
“3 patients in the MCT group (patient numbers 10, 24, and 37, Figure 4)” should be replaced 
with  
“2 patients in MCT groups (patient numbers 10 and 37, Figure 4)” 
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Summary of thesis 
Coronary atherosclerosis is a leading cause of morbidity and mortality worldwide. Physical 
inactivity is an independent risk factor for coronary artery disease, and physically active 
patients have an improved prognosis compared to sedate patients. Although the clinical 
relationship between exercise and cardiovascular health is convincing, the pathophysiological 
mechanisms responsible for improved outcomes in this large patient group are largely 
unknown.  
In a randomized controlled trial, we assessed exercise-induced effects on coronary 
atherosclerosis in 36 patients with established coronary artery disease undergoing stent 
implantation and optimal medical therapy. Patients exercised for 12 weeks, either following 
an aerobic interval training protocol, or performing moderate continuous exercise. Coronary 
atherosclerosis was assessed by grayscale and radiofrequency intravascular ultrasound, 
quantifying both plaque geometry and tissue characteristics. Our main findings were that with 
both exercise protocols there was a significant reduction in necrotic core (≈ 3 %) and a strong 
trend towards a reduction of plaque burden (≈ 10 %) in non-stented coronary segments and in 
separate atheroma lesions. There were no differences between exercise groups.  
In a post-hoc analysis of data from the randomized controlled trial, we assessed clinical 
factors at baseline that potentially were associated with a reduction in necrotic core and 
plaque burden at follow-up. We found a strong association between the clinical presentation 
of disease and necrotic core volume reduction after aerobic exercise (p=0.011). The 
association was in favor of patients with stable coronary artery disease, and necrotic core 
volume reduction was much more frequent in these patients (17/18) than in patients with 
unstable coronary artery disease (8/18). There were no significant associations between any 
clinical baseline explanatory variables and plaque burden reduction at follow-up.   
In a third study conducted within a subgroup of patients included in the randomized 
controlled trial, we assessed the reproducibility of intravascular ultrasound data acquisition in 
stented coronary arteries. This was performed by repeating the intravascular ultrasound 
pullback twice at the same time-point, thus simulating data collection in a serial imaging 
study. Our main finding was that the inter-pullback reproducibility of geometrical data was 
very good for non-stented segments with relative differences between pullbacks < 5 %. For 
stented segments reproducibility was poorer, though acceptable, and < 10 %.  
Taken together, the data presented in this thesis strengthens the scientific evidence for 
beneficial exercise-induced effects on coronary atherosclerosis, not only with respect to 
atherosclerotic burden, but also with respect to plaque vulnerability. Furthermore, exercise-
induced effects on coronary atherosclerosis may be more beneficial in patients with stable 
coronary artery disease compared to patients in the early phase after an acute coronary 
syndrome. Finally, serial intravascular ultrasound imaging in stented coronary arteries seems 
to be associated with a variability of 5–10 % attributed to the acquisition of images itself, 
which may have implications for the design of future serial stent studies. 
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1 Introduction 
1.1 Coronary artery disease 
Coronary artery disease (CAD) is the most common cause of heart disease and the single most 
prevalent cause of death in the developed world 1. Mortality rates from CAD and 
cardiovascular disease (CVD) in general are declining in affluent countries 2, but continues to 
rise in in low- and middle-income countries 3-5. CAD is projected to remain the leading cause 
of death worldwide for the indefinite future 6. 
In 2012, CVD accounted for approximately 13 000 deaths in Norway 7, and CAD was 
the single most important cause within this group (Figure 1). In 2013, a total of 13 043 
myocardial infarctions in 12 336 patients were recorded in the Norwegian Myocardial 
Infarction Registry 8 . Of these, 28 % were classified as ST-elevation myocardial infarctions 
and 70 % were classified as non-ST-elevation myocardial infarctions (NSTEMI). The 30-day 
mortality in the entire population was approximately 10 %. 
   
Figure 1. Causes of deaths in Norway 2012 (left), and etiology of deaths from CVD in Norway 2012 (right). Pie 
charts based on data from Statistics Norway 7.  
CVD
Malignant
neoplasms
Respiratory
diseases
Other diseases
Accidents,
suicide and
homocide
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Non-modifiable risk factors for CAD include a genetic predisposition, age, and male 
gender. CAD is also strongly associated with life-style factors, such as obesity, hypertension, 
hyperglycemia, hypercholesterolemia, tobacco use, unhealthy diet, and physical inactivity9-15. 
Many of these modifiable risk factors are closely associated through joint pathophysiological 
mechanisms that include low-grade chronic inflammation (see 1.1.1), endothelial dysfunction, 
and insulin resistance.  
Population-based strategies aiming to reduce the CVD risk burden have been 
successful in many countries with respect to tobacco use. However, recent studies show that 
the prevalence of obesity and physical inactivity is high 16,17, and increasing 18. Thus, new 
strategies in the prevention of CAD and CVDs need to target the fact that populations are 
gaining weight and become less physically active. 
  
1.1.1 Pathophysiology of atherosclerosis 
The vast majority of coronary artery disease is caused by coronary atherosclerosis. 
Atherosclerosis originates mainly at sites of bifurcation or branching points in the arterial 
system, which are areas where endothelial shear stress is low or oscillating 19, and therefore 
favours transport of blood components across the vessel wall. Atherosclerosis can be defined 
as a chronic inflammatory condition initiated in the endothelium in response to injury, and 
maintained through the interactions between modified lipoproteins, particularly low-density 
lipoprotein cholesterol, T-lymphocytes, monocyte-derived macrophages, and the normal 
constituents of the arterial wall 20. Atherosclerosis develops from the normal intima, to 
atheroma precursors, and finally to advanced atherosclerotic lesions, depending on the 
presence of cardiovascular risk factors and chronic inflammation. 
Endothelial dysfunction is thought to represent the initial stage of atherosclerosis 21. 
The normal endothelium maintains vasodilatory properties of arteries, regulating vascular 
17 
 
homeostasis, and inhibiting inflammation, cell adhesion and intravascular coagulation 22. 
When exposed to disturbances in endothelial shear stress (see 1.3.2), biomechanical forces 
from hypertension and the presence of other cardiovascular risk factors, the endothelium loses 
its normal properties. Endothelial actions shift towards vasoconstriction and dysregulation of 
vascular homeostasis, a phenomenon named endothelial dysfunction23. 
An increased expression of cell adhesion molecules and inflammatory mediators 24 on 
the endothelial surface occurs in the dysfunctional endothelium, allowing different leukocytes 
to enter the arterial wall 25. In the intima, monocytes differentiate into macrophages 26, and a 
subendothelial retention of lipids 27, particularly low-density lipoproteins, initiates chronic 
inflammation 28. Low-density lipoproteins are subjected to oxidation and enzymatic 
modification, giving rise to oxidized low-density lipoproteins, which promotes atherosclerosis 
(Figure 2)29.  
 
 
Figure 2. Vascular inflammation and development of early atheromas. See text for details. LDL; low-density 
lipoprotein, oxLDL; oxidized low-density lipoprotein. Figure designed by Chris Eliassen on request. 
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Macrophages engulf lipids from the subendothelial space and take the appearance of 
foamy structures, called foam cells. These cells release growth factors and cytokines which 
stimulate migration and proliferation of smooth muscle cells and myofibroblasts, and 
formation of a fibrous cap covering the atheroma follows. Further progression of 
atherosclerosis is characterized by increased lipid retention and inflammation. This 
development is driven by interactions between different subsets of activated macrophages and 
T-lymphocytes 26,30. The M1 macrophage, which inhibits tissue proliferation and causes tissue 
damage31, has recently been identified as important with respect to the development of 
unstable plaques 32.  
 
1.1.2 Coronary atheromas 
The main components of atherosclerotic plaques are connective tissue (extracellular matrix, 
collagen, proteoglycans and elastic fibers), cholesterol and phospholipids, immune cells, 
smooth muscle cells and thrombotic material 27. Different variations of these components give 
rise to a variety of heterogeneous lesions with different clinical significance, which are 
summarized in Table 1 33-35. 
There are three basic mechanisms that give rise to coronary thrombosis 32, which is the 
cause of rapid coronary occlusion giving rise to acute coronary syndromes (ACS). Plaque 
rupture of a vulnerable coronary plaque is the most common mechanism and is present in 
approximately 70 % of cases. Plaque erosion 27, due to loss or dysfunction of the lumen 
endothelial cells, is the principal mechanism in 25-30 % of cases, while calcified nodule is a 
rare cause of coronary thrombosis related to disruptive nodular calcifications protruding into 
the coronary lumen.  
The dynamic balance between the synthesis of collagen and degradation in the cap of 
the plaque determines the plaque’s fragility, and thereby the risk of rupture or erosion (plaque 
19 
 
vulnerability) 36. Generally, type I, II and III lesions (Table 1) are asymptomatic, while type 
IV lesions are stable plaques, which may clinically present as angina pectoris when the 
coronary stenosis reaches a certain level. Type V lesions, and particularly when a thin and 
inflamed cap is present (thin-capped fibroatheroma), are considered unstable plaques.  
 
Lesion type Characteristics Note 
Type I Increased numbers of 
macrophages, filled with lipid 
droplets, appear as foam cells. 
Represent the very initial changes. 
These lesions are also found in 
children. 
Type II Layers of foam cells within layers 
of smooth muscle cells. 
“Fatty streak”, the first 
macroscopically visible lesion. 
Type III Pools of extracellular lipids. “Pathological intimal thickening” 
and represent transition to 
atheromas. 
Type IV Lipid core of extracellular 
cholesterol and phospholipids 
intermixed with normal intima. 
Atheromas 
Type V Va: Lipid core covered by an 
acquired fibrous cap. 
Vb: Increased extent of 
calcification within the lesion. 
Vc: Increased extent of fibrous 
tissue within the lesion. 
Va are fibroathermoas or thin 
capped fibroatheromas.  
Vb lesions are calcific lesions.  
 
Vc lesions are fibrous lesions. 
Type VI Acute complicated type IV and V 
lesions with rupture or erosion.  
Leading to different clinical 
entities depending on the nature of 
the thrombosis. 
 Table 1. Different morphological lesions types of coronary plaques with characteristics. 
 
1.1.3 Diagnosis and treatment of coronary artery disease 
Atherosclerosis is usually a silent disease for decades, until an acute event or a gradual 
obstruction of the artery lumen causes clinical symptoms. The clinical presentations are 
heterogeneous, and include silent ischemia (no symptoms), stable angina pectoris (no 
symptoms at rest), unstable angina pectoris (symptoms at rest or in light activity, but no 
20 
 
pathological concentrations of troponin in blood), myocardial infarction (with or without 
changes in the electrogradiogram, but always with troponin concentrations above the cut-off 
level for normal values), or sudden death.  
ACS is a common designation for unstable angina pectoris and myocardial infarction 
combined. The biomarker troponin and the electrocardiogram are the most important 
diagnostic tools in the initial assessment of patients with suspected ACS, and determinative 
for further treatment (Figure 3). Patients included in this thesis were diagnosed with stable 
coronary artery disease (SCAD, equivalent to angina pectoris) and non-ST-elevation ACS 
(NSTE-ACS, including unstable angina pectoris and NSTEMI). These conditions are 
therefore further discussed below. 
  
Differential diagnostics in suspected acute coronary syndrome 
Rule out: 
 Pulmonary embolus 
 Aortic dissection 
 Pneumothorax 
 
      
ECG with ST-elevation or LBBB 
 
ST-elevation acute myocardial infarction  
(STEMI) 
ECG without ST-elevation or LBBB 
 Troponin rise and fall  
 Troponin normal 
 
Non-ST-elevation acute myocardial infarction (NSTEMI) 
Unstable angina pectoris (or other cause) 
Figure 3. Differential diagnostics in suspected ACS. LBBB; left bundle branch block. Modified from ESC 
Guidelines 37. 
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SCAD is caused by a gradual and progressive narrowing of one or several coronary 
arteries. In situations where there is an increased demand of blood to the myocardium 
(increased work load), the arterial narrowing causes an imbalance between the need and 
supply of oxygenated blood. Thus, the most typical feature of SCAD is that patients are 
symptomatic during activity and symptom-free at rest when the need for oxygenated blood is 
relatively low. SCAD is diagnosed on the basis of symptoms (most often chest pain, 
functional dyspnea, fatigue) and findings in non-invasive tests (Table 2) and/or coronary 
angiography (section 1.2.1).  
 
Test Diagnosis of coronary artery disease 
 Sensitivity (%) Specificity (%) 
Exercise electrocardiogram 45-50 85-90 
Exercise stress echocardiography 80-85 80-88 
Exercise stress single photon emission computed tomography 73-92 63-87 
Dobutamin stress echocardiography 79-83 92-95 
Dobutamin stress magnetic resonance imaging 79-88 81-91 
Vasodilator stress echocardiography 72-79 92-95 
Vasodilator stress single photon emission computed tomography 90-91 75-84 
Vasodilator stress magnetic resonance imaging 67-94 61-85 
Coronary computed tomography angiography 95-99 64-83 
Vasodilator stress positron emission tomography 81-97 74-91 
Table 2. Characteristics of tests used to diagnose coronary artery disease. Modified from ESC Guidelines 38. 
 
All patients with SCAD should have an anti-platelet agent and be considered for anti-
ischemic therapy, such as beta-blockers and vasodilatory drugs. Treatment of co-existing risk 
factors for CAD, such as hypercholesterolemia and hypertension, is also mandatory. The main 
indication for coronary revascularization is symptoms despite optimal medical therapy 39. The 
choice between percutaneous coronary intervention (PCI) and surgical revascularization 
depends on the extent of CAD (assessed by coronary angiography) and co-morbidity. 
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NSTE-ACS is a medical emergency and all patients should be hospitalized. 
Pathological findings in the electrocardiogram may be present or not. Since platelet activation 
and aggregation play a pivotal role in arterial thrombosis formation, all patients should 
receive a double anti-platelet regimen at admission, which usually includes acetylsalicylic 
acid and an inhibitor of adenosinephosphate-mediated platelet aggregation. Anticoagulants 
are also used to inhibit thrombin generation. Anti-ischemic treatment such as betablockers 
and/or nitroglycerin is given when indicated, and early treatment with statins is 
recommended. Guidelines recommend evaluation with coronary angiography and, if 
indicated, coronary revascularization within 72 hours after the onset of symptoms in most 
patients 37.  
 
1.2 Invasive imaging of coronary artery disease 
There has been a tremendous development in imaging modalities for CAD over the past 
decades, making it feasible to assess coronary atherosclerosis in vivo on a detailed level that 
previously only was available post mortem. These improvements have been utilized by 
clinicians to provide better patient care, and have also given new insight into coronary 
biology. 
 
1.2.1 Coronary angiography 
The angiogram is considered the gold standard in the diagnostics of CAD 38,40, and is used to 
determine whether a patient has significant disease (i.e. ≈ > 50 % diameter reduction of the 
artery lumen) and the patient’s suitability for percutaneous or surgical revascularization. The 
procedure is done in local anesthesia with the patient awake. A catheter is introduced into the 
radial or femoral artery, and X-ray images are taken of both coronary arteries from different 
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angles to visualize all segments as a planar silhouette of the lumen. A contrast medium is 
injected intracoronary for each view that is taken. The most common complication associated 
with angiography is local bleeding, which most often is treated with compression and bed 
rest. Contrast nephropathy is less common after the introduction of new and less toxic contrast 
agents. Major cardiovascular events and fatal outcomes are rare 41. 
Measurement of fractional flow reserve (FFR) is performed during coronary 
angiography, and is considered the gold standard for invasive assessment of ischemia 40. FFR 
of coronary arteries is defined as the maximum coronary artery flow in the presence of a 
stenosis divided by the theoretical normal maximum flow of the same artery. Measurement of 
FFR is based on pressure recordings distal and proximal to the stenosis during maximal 
vasodilation with adenosine. FFR < 0.75-0.80 indicates a hemodynamic significant coronary 
stenosis.  FFR measurement  is used in situations where the indication for treatment based on 
the angiogram itself is not conclusive 42.  
 
1.2.2 Intravascular ultrasound 
Coronary angiography has some major limitations, the most important being underestimation 
of true disease severity due to diffuse coronary atherosclerosis or coronary remodeling 43. 
Intravascular ultrasound (IVUS) overcomes some of these limitations, as it visualizes the full 
thickness of the vessel wall in cross-sectional images. The IVUS equipment consists of a 
catheter with an ultrasound transducer and a console, and the method is always used in 
association with coronary angiography.  
The reconstructed image is formed by the amplitude of the reflected ultrasound waves 
from tissue components in the artery wall, which are converted to electrical signals and sent to 
an external processing system for reconstruction (Figure 4) 44. The brightest echo is given 
from the intima bordering the lumen, and from the border between the external media and 
24 
 
external elastic membrane boarding the adventitia.  A motorized pullback with constant 
pullback speed is used, and therefore, distances between the cross-sectional images are known 
and one may calculate distances, areas and volumes of vessels, stents and plaques. Thus, 
IVUS enables an assessment of both the extent and severity of coronary atherosclerosis.  
IVUS is limited with respect to different plaque components due to its low spatial and 
axial resolution 45. Characterization of plaques by IVUS is therefore based on visual 
appearance alone, and is displayed in black and white, so-called gray scale, GS-IVUS. Thus, 
differentiating between for instance a thrombus and a lipid-rich plaque may be difficult due to 
the fact that the echoes reflected from these tissue components are similar. Another limitation 
of IVUS is the tendency of the catheter to stick or stall during pullbacks due to friction 
between the catheter and the vessel. In these situations the reflected image may contain false 
dimensions. This issue is further discussed in section 1.2.4 and in Paper 3.   
 
 
Figure 4. Schematic overview of acquisition of intravascular ultrasound data.  
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For clinical purposes, IVUS is recommended in selected patients to optimize stent 
implantation, to assess severity and to optimize treatment of unprotected left main lesions, and 
to assess mechanisms of stent failure 40. Relative contraindications for IVUS are small arteries 
(diameter < 1.5 mm), severe vessel tortuosity, and old venous grafts with general 
atherosclerosis 46.  
 
1.2.3 Radiofrequency IVUS-based plaque classification  
Several post-processing methods have been developed to further characterize tissue and 
atherosclerotic lesions. Radiofrequency analysis (RF-IVUS) or spectral analysis of 
intravascular ultrasound data, also called intravascular ultrasound virtual histology (Figure 5), 
uses the underlying frequency of the reflected ultrasound waves to analyze tissue components 
47,48. RF-IVUS has been correlated with vascular tissue determined from histology with high 
accuracy 49,50, and characterizes four different vascular tissue types based on the spectral 
signature of the reflected sound waves; fibrous tissue, fibro-fatty tissue, dense calcium and 
necrotic core (Figure 5).  
 
 
Figure 5. Assessment of a 
plaque in the left descending 
coronary artery using RF-
IVUS. Different color-codes 
are used to identify different 
tissue types. Green = fibrous 
tissue, green – yellowish  = 
fibro-fatty tissue, white = 
dense calcium, and red = 
necrotic core.  
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Based on pathological data, six different lesion types based on RF-IVUS criteria have been 
proposed (Table 3), with an additional hypothesis of evolutionary order and degree of 
vulnerability. This order suggests that the fibrocalcific plaque is the most advanced, and the 
virtual histology thin cap fibroatheroma is the most vulnerable plaque 51.  
 
Lesion type Description  
Intimal medial thickening <600 μm of intima thickness 
Pathological intimal thickening ≥600 μm thickness for >20 % of the circumference with fibro-fatty 
tissue > 15 %, and no confluent necrotic core or dense calcium 
Fibrotic plaque Dominant fibro-fatty tissue and no confluent necrotic core or dense 
calcium 
Fibrocalcific plaque >10 % confluent dense calcium with no confluent necrotic core 
Fibroatheroma >10 % confluent necrotic core on three consecutive frames 
Virtual histology thin cap fibroatheroma >10 % confluent necrotic core on three consecutive frames and arc 
of necrotic core in contact with the lumen for 36 degrees along 
lumen circumference 
Table 3. Classification of RF-IVUS lesions types, with proposed increased vulnerability from top to bottom in 
the table, adapted from Garcia-Garcia et al 51. FT; fibrous tissue, FF; fibro-fatty tissue, NC; necrotic core, and 
DC; dence calcium.  
 
The Providing Regional Observations to Study Predictors of Events in the Coronary 
Tree (PROSPECT) investigation followed 697 patients with ACS with a median follow-up of 
3.4 years 52. All patients included in the study underwent GS- and RF-IVUS of all three 
epicardial vessels and major cardiovascular events during follow-up were adjudicated to 
either originally treated lesions (culprit) or untreated lesions. The main finding of this study 
was that acute events during follow up were equally attributable to recurrence of disease at 
culprit lesions and to non-culprit lesions. Furthermore, non-culprit lesions that were 
responsible for events were frequently angiographically mild, and characterized as thin-
capped fibroatheromas or with a large plaque burden 52.  These findings are important as they 
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tell us that not only plaque geometry or plaque size, but also plaque composition, is pivotal in 
plaque risk assessment 53. Whether coronary plaques being defined as vulnerable by RF-IVUS 
or other imaging modalities (see 1.2.5) should be invasively treated is the subject of ongoing 
trials. 
 
1.2.4 Reproducibility of IVUS data 
As in any methodology, the reproducibility of both image acquisition and data analysis are 
pivotal issues when working with IVUS. The issue of reproducibility may be particularly 
important with respect to IVUS, as changes in plaque characteristics are generally small in 
serial clinical trials.  
Several studies have documented that the analysis of IVUS measurements is highly 
reproducible, both in non-stented 54 and stented coronary segments 55-57. The reproducibility 
of IVUS data acquisition is also found acceptable in non-stented segments 58,59. However, 
there is a paucity of data on accuracy between repeated pullbacks from intervened vessels. 
Implanted stents may represent a particular problem due to a higher tendency of the IVUS 
catheter to stick or stall during pullbacks through these segments. Variability in data 
acquisition from stented coronary segments may therefore represent a source of error that 
could have implications for the design of serial stent studies. 
 
1.2.5 Other imaging modalities 
The most established non-invasive imaging modality for CAD is coronary computed 
tomography angiography. The method visualizes coronary calcification, lumen narrowing and 
to some degree plaque composition. It is limited by false positive results in the presence of 
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severe calcification or motion artefacts 60, and is recommended  as an alternative to an 
invasive strategy in the diagnosis of SCAD in patients with low to moderate risk 38.  
Optical coherence tomography (OCT) is an invasive method that uses near-infrared 
light to produce cross-sectional images of coronary arteries. The method has a very high 
resolution and may therefore be used to study various morphological features of CAD 61, 
including struts of implanted stents. It is limited by its weak ability to detect vulnerable 
plaques. OCT is currently being recommended in the assessment of stent failure and to 
optimize stent implantation 40.  
Near-infrared-spectroscopy (NIRS) is a novel method for invasively detection of lipid 
content in plaques 62 and is currently only being recommended for use in research. Images are 
displayed as a chemogram, which shows the scanned artery segment as a map, and the 
probability of lipid is displayed in a color code from red (low probability) to yellow (high 
probability).  
 
1.3 Physical activity in coronary artery disease 
The association between physical activity and reduced risk of CAD has been known for many 
decades 63, and confirmed in several studies, also in a Norwegian population 64. Physical 
inactivity is identified as an independent risk factor for CVD 65 and estimations propose that 
one fifth of CVDs are related to  by physical inactivity 66. Inactivity is also closely related to 
the development of obesity, diabetes mellitus and hypertension, which all represent 
independent cardiovascular risk factors. It is therefore not surprising that physical exercise is 
associated with reduced morbidity and mortality in subjects with established CVDs 67-69. In 
fact, a recent meta-analysis showed no detectable differences between exercise and drug 
intervention in the secondary prophylaxis of CAD 70, emphasizing the importance of 
“prescribing” physical activity as treatment equally to cardiovascular drugs in this patient 
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group. The mechanisms responsible for the favorable effects of physical activity in CAD 
patients are not completely understood, and may include both modification of CAD risk 
factors 71 and a direct effect on coronary atherosclerosis. 
 
1.3.1 Aerobic fitness and exercise intensity 
Aerobic fitness or exercise capacity is defined by the maximal oxygen uptake (VO2max), 
which is the highest uptake of oxygen during strenuous exercise using large muscle groups. 
VO2max  is defined as the product of cardiac output and arteriovenous oxygen difference 
(Fick’s equation): 
 
 VO2max = (Heart rate x stroke volume) x (ArterialO2 - VenousO2) 
 
VO2max is limited by both central (cardiovascular and pulmonary) and peripheral (skeletal 
muscle) factors, with central factors as most important. It is argued that peripheral factors are 
more important in unfit subjects (such as the majority of patients with established CAD) 
compared to fit ones72. 
The peak oxygen uptake (VO2peak) is the highest uptake of oxygen obtained during a 
cardiopulmonary exercise test, and is often used as a surrogate of VO2max. VO2peak is found to 
be the single best predictor of both cardiac and all-cause mortality among patients with 
established CVD 68 as well as healthy subjects. This is reflected by the fact that physical 
activity is a cornerstone in the secondary prophylaxis of patients with established 
atherosclerotic disease. Recommendations on aerobic exercise in CAD patients were revised 
and published in a joint statement document in 2012 73, recommending the following: exercise 
3-5 times per week, adequate warm-up of 15 minutes, moderate to high intensity for 20-40 
minutes, and cool-down for 5-10 minutes. The recommendations do not distinguish between 
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SCAD and ACS patients, but calls for care in patients with anterior or apical myocardial 
infarctions and poor left ventricular function. 
Aerobic interval training (AIT) is repeated intervals of exercise with short duration 
and intensity above the lactate threshold of the subject. After each interval, the subject has an 
active break, with lower intensity allowing some degree of recovery 74. Previous studies have 
demonstrated that AIT is superior to moderate continuous training (MCT) with respect to 
improving fitness (Figure 6)  and endothelial function in patients with CAD 75-78, heart failure 
79 and metabolic syndrome 80. A recent study demonstrated the high safety of both MCT and 
AIT in patients with CAD 81, arguing in favor of the use AIT in cardiac rehabilitation due to 
its superior effect on VO2peak.  
 
 
 
Figure 6. Superiority of AIT versus MCT in improving VO2peak in patients with CAD. Re-printed with 
permission from Moholdt et al 75. 
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1.3.2 The endothelial shear stress hypothesis 
Endothelial shear stress can be defined as the stress exerted by the blood flow parallel to the 
vessel wall (also called laminar shear stress). In healthy subjects, exercise training induces 
acute alternations in blood flow and endothelial shear stress, the frequency of pulsatile 
pressure, and systolic blood pressure 82. Generally, arteries adapt to these forces with 
structural changes, such as enlargement of the vessel diameter, due to induction of flow-
induced vasodilation via a healthy endothelium. This adaption results in normalization of 
endothelial shear stress, and increased blood flow, but not increased flow velocity 83. In the 
coronary circulation, most of the blood flow at rest occurs during diastole. During exercise, 
coronary blood pressure becomes pulsatile with flow in both systole and diastole, and 
coronary blood flow is increased five-fold 82. Endothelial shear stress increases intermittently 
parallel to increased cardiac output during exercise, and is a potent signal for the integrity and 
survival of endothelial cells 84, potentially affecting 3 000 endothelial cell genes 85.  
The focal distribution of coronary plaques, despite the fact that the entire vasculature 
is exposed to the same level of systemic risk factors, is attributed to local hemodynamic 
forces. Endothelial shear stress exerted upon an endothelial cell within the vasculature is a 
direct function of the vessel geometry in that region. Thus, hemodymanic forces and changes 
in endothelial shear stress interacting with the endothelium have been implicated in the 
pathophysiology of CAD 86. Generally, low endothelial shear stress is considered pro-
atherogenic 87 via its effect on coagulation, leukocyte and monocyte migration, smooth 
muscle growth, lipoprotein uptake and endothelial cell survival 86. Thus, low endothelial shear 
stress contributes to the focal distribution of CAD and negative remodeling 88,89. A central 
hypothesis in explaining the beneficial effects of exercise in the prevention and treatment of 
atherosclerotic disease is that exercise produces increased arterial endothelial shear stress, 
which results in an anti-atherogenic endothelial phenotype 90. This hypothesis was supported 
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in a porcine model that demonstrated that low endothelial shear stress promoted the initiation 
and progression of atherosclerotic plaques 91. Another study found that coronary segments 
with high endothelial shear stress at baseline underwent the largest reduction in plaque burden 
at follow-up 52.  
However, some evidence also suggest that high endothelial shear stress may contribute 
to the development of  plaque vulnerability 92, which could be detrimental for patients with 
established CAD. In a study using RF-IVUS and computational fluid dynamics modeling 93, it 
was demonstrated that coronary segments with low endothelial shear stress developed greater 
plaque volume, progression of necrotic core and constrictive remodeling. Coronary segments 
with high endothelial shear stress developed greater necrotic core and excessive expansive 
remodeling.  
 
1.3.3 Current evidence for exercise-mediated effects in coronary arteries  
Exercise training, as part of a multi-intervention program, has been found to attenuate the 
progression of coronary atherosclerosis evaluated by coronary angiography 94,95. It has also 
been demonstrated that regular exercise slows the progression of coronary plaques in 
hypercholesterolaemic animal models 96, supporting the hypothesis that exercise induces 
beneficial changes in coronary atherosclerosis. Improvement of endothelial function, the 
formation of collaterals and new vessels by vasculogenesis, and reduced arterial stiffness have 
also been proposed as mechanisms for the positive exercise-mediated effects in patients with 
established CAD (Table 4) 83,97-101.  
There is also evidence for beneficial effects of physical exercise after PCI and stent 
implantation. In the Exercise Training Intervention after Coronary Angioplasty (ETICA)-trial, 
patients were randomized to MCT or usual care after coronary angioplasty and/or stent 
implantation. Improved fitness and a lower extent of restenosis, coronary events and hospital 
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readmissions were found in the intervention group 102. In another study it was demonstrated 
that AIT was associated with a significant reduction in late luminal loss in stented coronary 
segments evaluated by coronary angiography 103, which suggests that AIT may reduce in-stent 
restenosis.  
Mechanism Signaling pathway 
Improved endothelial function Increased HDL concentrations 
Increased endothelial nitric oxide synthase 
Decreased generation of reactive oxygen species 
Increased bioavailability of nitric oxide 
Increased amount of endothelial progenitor cells 
Vasculogenesis Decreased generation of reactive oxygen species 
Increased levels of stromal-derived factors and 
vascular endothelial growth factor 
Mobilization of stem cells  
Reduced arterial stiffness Reduced collagen I and III 
Decreased expression of tumor growth factor beta 
Reduced levels of advanced glycation end-products 
Table 4. Proposed signaling pathways for beneficial exercise-mediated effects via increased ESS.  
 
As outlined above, although epidemiological and clinical data support that exercise 
training has a variety of beneficial effects for both healthy and diseased subjects, there is a 
paucity of data assessing exercise-induced effects on coronary atherosclerosis, particularly 
with the use of modern imaging techniques, such as IVUS. To date, no data on plaque 
composition and exercise in native coronary arteries exist.  The main objective of the current 
thesis was therefore to assess exercise-induced effects on the coronary artery wall and 
coronary atherosclerosis using IVUS-based imaging modalities.  
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2 Hypothesis and aims of the thesis  
 
We hypothesized  
 That regular aerobic exercise for 12 weeks would induce a general increase in 
coronary endothelial shear stress and that beneficial changes in coronary plaque 
geometry and composition would follow. 
 
 That the increase in endothelial shear stress would be larger in subjects exercising with 
high intensity (AIT) compared to moderate intensity (MCT) and that beneficial 
changes in coronary plaque geometry and composition would be larger in AIT versus 
MCT.  
 
 That potential beneficial changes in coronary plaques also depend on clinical factors 
other than the exercise intervention given.  
 
 That the IVUS inter-pullback reproducibility in stented coronary segments would be 
poorer than in non-stented segments. 
 
The specific aims of the thesis were 
a) To assess the effects of AIT versus MCT on coronary artery plaque geometry in 
patients with significant CAD on optimal medical treatment using GS-IVUS. 
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b) To assess the effects of AIT versus MCT on coronary artery plaque composition in 
patients with significant CAD on optimal medical treatment using RF-IVUS. 
 
c) To assess baseline clinical factors that may be associated with beneficial changes in 
coronary artery plaque geometry and composition in CAD patients undergoing an 
aerobic exercise intervention.  
 
d) To compare data from two repeated volumetric GS-IVUS and RF-IVUS pullbacks at a 
single time-point, thereby assessing inter-pullback variability in different diseased 
segments in stented coronary arteries. 
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3 Material and methods 
The present thesis is based on a single-center, open, parallel, randomized controlled trial 
(Paper 1 and 2), and a cross-sectional study (Paper 3). Patients were recruited for the two 
studies simultaneously.  The study protocol was registered at ClinicalTrials.gov (identifier 
NCT01228201), and performed according to the Helsinki declaration. Written informed 
consent was obtained from all study participants. Ethical considerations are discussed in 
section 3.7.     
 
3.1 Patients 
Patients were recruited from the Department of Cardiology at St. Olavs Hospital, Trondheim, 
Norway, from December 2010 to April 2012. Inclusion criteria were age > 18 years and 
angiographically significant CAD, presented as SCAD or NSTE-ACS, and treated with 
intracoronary stent implantation. A total of 412 patients were screened for participation before 
scheduled coronary angiography, and excluded if they met one or more of the following 
exclusion criteria: 
 Inability to perform regular exercise due to comorbidity or work situation 
 ST-elevation myocardial infarction 
 Non-significant CAD or referral to coronary artery bypass surgery 
 Previous surgical revascularization 
 Coronary anatomy not suitable for IVUS 
 Arrhythmias including atrial fibrillation 
 Planned surgery within four months  
 Inclusion in another randomized trial 
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3.2 Study design 
All included patients participated in the randomized trial (Paper 1 and 2). Baseline coronary 
imaging was performed following patient consent (see 3.4), and baseline non-invasive data 
collection was scheduled 7-10 days after PCI (see 3.3). Following completion of baseline data 
collection, patients were randomized to AIT or MCT. Randomization was performed by a 
web-based randomization system developed and administered by Unit of Applied Clinical 
Research, Institute of Cancer Research and Molecular Medicine, Norwegian University of 
Science and Technology, Trondheim, Norway. Data collection at follow-up was scheduled 2-
3 days after completed exercise intervention. A subgroup of patients was randomly picked as 
participants in the cross-sectional study (Paper 3). In these patients, a second IVUS pullback 
was performed 5-10 minutes after the first one, either at baseline or at follow-up. Figure 7 
shows a flow diagram of enrollment, randomization, follow-up and data analyses in Paper 1, 2 
and 3. 
In the randomized trial, a difference in cross-sectional plaque area between exercise 
groups of 40 %, which corresponds to 2.7 mm3 104 was estimated. To show this difference 
with a power of 80 % using a 2-sided test with α=0.05, 19 patients in each group, i.e. 38 
patients, were needed 105. No power calculations were made for the reproducibility study 
(Paper 3), and it was aimed at including approximately 15 patients based on previous data 
from the study by Hartmann et al 58.   
 
3.3 Clinical variables and non-invasive data  
Information on health, including previous CVDs and medication, was collected from the 
hospital medical records. Patients were asked about their use of tobacco, categorized as 
current smoker, previous smoker or never smokers. They were also asked to assess their usual 
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level of physical activity, classified as inactive if they reported less than 1 hour of hard 
activity or less than 3 hours of light activity per week, moderately active if they reported 1 to 
3 hours of hard activity or above 3 hours of light activity per week, or physically active if they 
reported more than 3 hours of hard activity per week.  
 
Figure 7. Overview of the studies included in this thesis. See text for details. 
39 
 
level of physical activity, classified as inactive if they reported less than 1 hour of hard 
activity or less than 3 hours of light activity per week, moderately active if they reported 1 to 
3 hours of hard activity or above 3 hours of light activity per week, or physically active if they 
reported more than 3 hours of hard activity per week.  
 
Figure 7. Overview of the studies included in this thesis. See text for details. 
Patients assessed for 
eligibility, n=412 
Patients 
randomized  
(Paper 1), n=41 
Patients analyzed 
(Paper 1), n=36 
Patients excluded 
n=371 
Second pullback in 
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(Paper 3) 
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1 patient lost to 
follow-up 
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Blood pressure was measured using an automatic blood pressure cuff (Welch Allyn, 
Germany). Height was measured to the nearest cm and body weight was measured to the 
nearest 0.1 kilogram. Body mass index was calculated as weight divided by the square of 
height. Waist circumference was measured to the nearest cm at the level of the umbilicus. The 
heart and lungs were examined with auscultation, and both legs were examined with respect 
to peripheral edemas at baseline and follow-up. A venous blood sample was drawn between 
8.00 am and 9.00 am after over-night fasting. The sample was analyzed for glucose, total 
cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, 
triglycerides, glycosylated hemoglobin, N-terminal pro-brain natriuretic peptide, and C-
reactive protein, using accredited in-hospital procedures. 
Quality of life was assessed by the Norwegian version of the “MacNew Heart Disease 
Health Related Quality of Life Questionnaire” (MacNew).  The questionnaire consists of 27 
items that are organized in three domains; emotional, social and physical, and evaluates how 
the patient’s daily activities and general functioning are affected by the disease and its 
treatment. The validity and reliability of the Norwegian version of MacNew has been 
documented 106.  
Endothelial-dependent vasodilation was estimated by flow-mediated vasodilation in 
the brachial artery by a 3-point echocardiography system using a 12-MHz Doppler Probe 
(Vivid 7 System, GE Vingmed Ultrasound, Horten, Norway). All measurements were 
performed according to current recommendations 107. The brachial artery was imaged after ten 
minutes of supine rest, and continuously for five minutes after cuff deflation. Images were 
analyzed by an independent observer using automatic edge detection software (Vascular 
Research Tools 5, Medical Imaging Applications LLC, Coralville, IA, USA). The percentage 
FMD normalized for shear rate was reported as recommended 108. 
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3.4 Invasive procedures    
Baseline coronary angiography was performed as part of the usual patient diagnostics and 
treatment. If a patient had signed the consent form, and was diagnosed with at least one 
epicardial stenosis requiring PCI with stent implantation, the patient was included in the study 
“on the table”. All invasive procedures were performed by very experienced invasive 
cardiologists and in accordance with current guidelines.  
 
3.4.1 Intravascular ultrasound imaging   
Following successful PCI, the index artery was imaged with GS-IVUS and RF-IVUS after 
intracoronary administration of 200 µg nitroglycerin. This was performed using the Eagle Eye 
Platinum IVUS 20 MHz probe (Volcano Corporation, Ranco Cordova, CA, USA). A fixed 
pullback rate of 0.5 mm/s (Volcano R 100 pullback device) was used to standardize 
volumetric calculations. RF backscattered data were collected with a dedicated console 
(Volcano Corporation) at every R-peak on the electrocardiogram.   
The IVUS probe was advanced as far distally into the index artery as possible, and at 
least > 10 mm beyond the distal stent edge. Thereafter, the probe was pulled back through the 
stented segment proximally into the ostium. For participants in the cross-sectional study 
(Paper 3) this procedure was repeated 5-10 minutes after the first pullback, using the same 
catheter. Another 200 µg nitroglycerin was administered before the second pullback.  
IVUS data were transformed to CDs for later offline analysis. Patients were observed 
in the ICU after the procedure and were usually discharged from the hospital within 1-3 days 
depending on clinical presentation and comorbidity. At hospital discharge, a follow-up was 
scheduled. 
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3.4.2 Analysis of intravascular data 
All intravascular data were analyzed by an independent core laboratory (Krakow 
Cardiovascular Research Institute, Krakow, Poland). All analysts were blinded to 
randomization group and clinical data. GS-IVUS and RF-IVUS data were analyzed by 
automatic contour detection of lumen and vessel by a dedicated program (QIvus software 2.1, 
Medis Medical Imaging System, Leiden, the Netherlands). The analyst had to optimize the 
automatically drawn contours through image characteristics settings in every single frame. All 
analyses were performed according to current recommendations51,109. The imaged artery was 
divided into five segments of interest (Figure 8);  
 distal reference: starting as distally as possible to 5 mm from the distal stent edge 
 distal edge: starting 5 mm distal to the stent edge, ending at the first cross-sectional 
image where the stent covered > 50 % of the vessel wall circumference (defined as 
stent edge) 
 stent: starting at the first frame after the distal stent edge and ending at the last frame 
before the proximal stent edge  
 proximal edge: starting at the proximal stent edge and ending 5 mm proximal to the 
stent edge  
 proximal reference: starting 5 mm proximal to the stent edge and ending as far 
proximally as possible  
 
 
Figure 8. Coronary index artery divided into 5 segments of interest for analysis. Modified from Paper 3 110. 
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Matched coronary segments at baseline and follow-up were identified using fiduciary 
points in the pullback, such as the implanted stent and side braches that were clearly visible in 
both pullbacks. Parts of segments that were not visible in both pullbacks (baseline and follow-
up) were excluded. This was the case in some patients as the catheter was placed more distally 
in the baseline pullback than in the follow-up pullback, or vice versa. Stented segments were 
excluded from all RF-IVUS analyses due to the artefacts from stent struts (usually visualized 
as white and therefore visually interpreted as dense calcium) in RF-analyses.  
Computed GS-IVUS parameters in the present thesis are listed and defined in Table 5.  
Note that the total atheroma volume was normalized for segment length due to large 
differences in total atheroma volume between patients, thereby providing equal weighting of 
each patient in the calculations. Normalization was done by dividing the total atheroma 
volume by segment length and multiplying with the median segment length in the study 
population.   
 
GS-IVUS parameter Definition 
Minimal lumen area The smallest cross sectional lumen area detected in the analyzed segment  
Total atheroma volume  
 
Cross-sectional area of external elastic membrane minus cross-sectional area 
of lumen, corresponding to plaque plus media area (Figure 9) 
Plaque burden Plaque plus media area divided by the external elastic membrane area 
Remodelling index Cross-sectional area of external elastic membrane at minimal lumen area 
divided by the cross-sectional area of external elastic membrane at the 
smallest plaque burden 
Table 5. Analyzed GS-IVUS parameters.  
 
The RF-IVUS parameters were computed based on spectral analysis of the 
backscattered RF data 111. Absolute volumes and percentage volumes of the four tissue 
components fibrous, fibro-fatty, necrotic core, and dense calcium components were analyzed. 
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Morphological patterns were identified as lesions with a plaque burden > 40 % over 3 
consecutive frames separated by 5 mm lengths of artery with a plaque burden < 40 % 51. Such 
lesions were classified as separate lesions. These lesions were classified according to the 
American Heart Association histological classification 112 adapted for RF-IVUS and in terms 
of vulnerability 51. Different regions of interest, segments, separate lesions, and study end-
points were defined for paper-specific sub-analyses, and are shown in Table 6. 
 
 
 
 
Paper # Segments of interest Analytic plan Study end-points 
Paper 1 Proximal and distal  
reference segments 
Whole segments and 
morphological patterns analyzed 
Change in plaque burden and necrotic 
core. Change in plaque vulnerability for 
separate lesions 
Paper 2 Proximal and distal  
reference segments 
Morphological patterns 
analyzed 
Clinical variables at baseline that were 
associated with change in plaque burden 
and necrotic core at follow-up 
Paper 3 All five segments Repeated pullbacks analyzed, 
only whole segments 
Actual and relative difference between 
pullbacks 
 Table 6. Segments of interest, analytic plan and study end-points of the papers included in this thesis.  
Figure 9. Calculation of total atheroma 
area (plaque plus media) in a cross-
sectional IVUS frame (unit mm2). The 
lumen area is subtracted from the 
external elastic membrane area. Total 
atheroma volume (unit mm3) is 
calculated by software when the segment 
length is included in the algorithm. 
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3. 5 Cardiopulmonary exercise testing 
Acquisition of non-invasive data other than exercise testing is described in section 3.3. All 
patients underwent a cardiopulmonary exercise test (repeated at follow-up, Paper 1 and 2) on 
treadmills (Woodway PPS55, Weil am Rhein, Germany). We used an individualized ramp 
protocol to last approximately 10 minutes. The majority of patients walked at a predefined 
speed, and the inclination was raised by 1-3 % every 1-2 minute until complete exhaustion. A 
few patients ran, and in these patients the inclination was held relatively constant at 2-5 % and 
the speed was increased every 1-2 minute until complete exhaustion. All patients were 
monitored with continuous electrocardiogram for safety reasons. Subjective perception of 
exhaustion was assessed immediately after termination of the test by Borg’s 6-20 scale 113. 
 Gas exchange data were analyzed continuously throughout the test (Oxycon Pro, 
Jaeger, Hoechberg, Germany). VO2peak was calculated as the mean of the 3 highest 
measurements during the test. Peak heart rate was defined as the highest heart rate during the 
test. Heart rate recovery was defined as peak heart rate minus the heart rate after one minute 
of complete rest standing on the treadmill.    
 
3.6 Aerobic exercise intervention  
The exercise protocols were based on protocols used in previous trials in our research group 
76-80. The rationale for using the AIT versus MCT protocols was to introduce isocaloric 
exercises 78 with different exercise intensity. Both exercise programs consisted of 36 sessions 
distributed over 12 weeks, i.e. 3 sessions per week. All patients used heart rate monitors 
(Polar Electro, Kempele, Finland) to help achieve target heart rate during exercise, which was 
calculated in advance based on the peak heart rate during baseline exercise testing. All 
sessions were supervised by an experienced physiologist or physician.  
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The AIT program consisted of 10 minutes of warm-up, followed by intervals of 4 
times 4 minutes with an active pause of 3 minutes in-between each interval and at the end. 
The target heart rate was 85-95 % of peak heart rate during intervals and 60-70 % of peak 
heart rate during the active pause (Figure 10). Most patients ran during intervals, and walked 
during the active pause. The MCT program consisted of continuous walking or light running 
for 46 minutes at ≤ 70 % of peak heart rate. The speed and inclination of the treadmill was 
individualized for all patients, and recorded together with the target heart rate at 2 minutes 
and at the end of each interval. An exercise diary was kept for all study participants. Patients 
in the MCT group were strongly encouraged not to perform exercise with high intensity 
outside the hospital during the intervention period. 
   
 
Figure 10. Aerobic interval training model used in Paper I and II. Peak HR = peak heart rate. Modified with 
permission from Trine Moholdt, Aerobic exercise in coronary heart disease, Doctoral thesis (2010).   
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3.7 Ethical considerations 
The study protocol was approved by the Regional Ethics Committee of Central Norway 
(identifier 2010/1112). The major issue discussed with the Ethics Committee was the use of 
invasive imaging in research. However, IVUS is considered safe and the risk for adverse 
events is low (<0.5 %)114.  
The use of an inactive control group was discussed prior to study registration at 
clinicaltrials.gov, but this was considered unethical due to the well-documented benefits of 
exercise in CAD patients 115. Furthermore, post-PCI patients at our hospital are offered 
cardiac rehabilitation as part of the routine, and it would have been problematic to deprive 
patients randomized to an inactive control group from this opportunity.   
 
3.8 Statistical methods 
Paper 1 Baseline data were compared between groups using the chi-square test or Mann-
Whitney U test. Data measured both at baseline and follow-up were analyzed using repeated 
measures analysis of variance and linear mixed models with maximum likelihood estimation. 
Separate lesions in each patient were clustered by patient number where appropriate. The 
proximal and distal reference segments were analyzed separately. Variables were 
logarithmically transformed if necessary to achieve adequate model fit. 
Paper 2 Statistical analysis was performed as variable screening followed by a final 
analysis. For the first screening step, the outcome variables were dichotomized into 
“reduction” versus “no change/increase”. Random forest analysis 116,117 (with bootstrapping, n 
= 2000) was then performed. Baseline explanatory variables that were screened for 
association with changes in plaque burden or necrotic core included age, sex, body mass 
index, smoking habits, hypertension, prior myocardial infarction, renal failure, diabetes 
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mellitus, clinical presentation at baseline (SCAD or NSTE-ACS), cardiovascular medication, 
blood biomarkers (C-reactive protein, glucose, glycosylated hemoglobin, total cholesterol, 
low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides), 
endothelial function (estimated as percent flow-mediated vasodilation), and peak oxygen 
uptake. In the second step, significant variables from the random forest analysis were further 
analyzed using multivariate robust linear regression with the outcome variables in the original 
continuous form (mm3). Model fit was evaluated by residual plotting.  
Paper 3 The actual difference and relative difference between each parameter in all 
five artery segments were calculated. The relative difference was normalized for the 
maximum value for the two measurements. Agreements between pullbacks (i.e. 
reproducibility) were also assessed visually using Bland-Altman plots by plotting the mean of 
the two measurements (pullback 1 and 2) on the x-axis and the difference between the two 
measurements on the y-axis.  
Statistical software In Paper 1 and 2 the statistical software SPSS (version 20.0, IBM, 
Chicago, IL, USA), Stata (version 13.0, StataCorp, College Station, TX, USA), and Minitab 
(version 16.2.1, Minitab, State College, PA, USA) were used. The statistical package JMP 
9.0.0 was used for statistical analysis and data visualization in Paper 3. 
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4 Summary of results 
Forty-one patients were included in the randomized controlled trial (Paper 1 and 2) and 15 
patients were included in the cross-sectional study (Paper 3). Drug-eluting stents (Xience 
Everolimus Eluting Stents, Abbot Vascular, Santa Clara, CA, USA, or Resolute Integrity 
Zotarolimus Eluting Stents, Medtronic Inc., Minneapolis, MN, USA) were used in 37 
patients, whereas four patients received bare-metal stents (Integrity, Medtronic Inc.). The 
choice of stents was based on clinical considerations by the physician performing stent 
implantation.  
One patient in the AIT group was excluded due to a cerebral hemorrhage, which 
occurred approximately 36 hours after completion of an exercise session. Otherwise, there 
were no adverse events in the study, and there were no procedural complications during 
invasive imaging. Furthermore, three patients did not complete intervention (two patients in 
the AIT group, and one patient in the MCT group), and data from one patient (AIT group) 
were not possible to analyze due to very poor imaging quality (Figure 7). 
The Core Lab analyzed inter- and intra-observer variability for RF-IVUS analyses. 
This analysis was performed in 221 regions of interest and showed good correlation between 
two different analysts (К = 0.79) and excellent correlation for a single analyst (К = 1). Of 
note, these analyses should not be mixed with the inter-pullback variability, i.e. variability in 
the acquisition of data itself, which was the study endpoint in Paper 3.  
    
4.1 Paper 1 “Coronary atheroma regression and plaque characteristics assessed 
by grayscale and radiofrequency intravascular ultrasound after aerobic exercise” 
The aim of the study was to assess exercise-induced effects on coronary artery plaque 
geometry and composition evaluated by GS- and RF-IVUS. The primary end point was 
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defined as change in plaque burden for the proximal and distal coronary segment and for 
separate lesions. The secondary endpoints were defined as change in necrotic core for the 
distal and proximal segment and for separate lesions and change in plaque vulnerability for 
separate lesions.  
Data from 36 patients (7 females) were included. Fifteen patients completed the AIT 
protocol, whereas 21 patients completed MCT. All patients completed at least 90 % of 
scheduled exercise sessions. Median ages in the two groups were 55.5 and 60.5 years, 
respectively. All patients received aspirin, clopidogrel and a statin. Twelve patients in the AIT 
group and 7 patients in the MCT group had used statins for > 6 months at study inclusion; 
otherwise statins were initiated at admission. VO2peak improved in both groups (p<0.001). In 
the AIT group VO2peak at baseline was 31.2 (29.1-34.0) mL*kg
-1*min-1, and at follow-up 34.5 
(32.3-37.9) mL*kg-1*min-1. The corresponding numbers in the MCT groups were 29.8 (27.5-
33.7) mL*kg-1*min-1 and 31.8 (29.1-35.4) mL*kg-1*min-1, corresponding to a significant 
between-group difference (p<0.05) in favor of AIT. A trend for improvement in FMD in both 
groups (p=0.07) was demonstrated, with no evidence of a difference between groups. All 
three quality of life parameters (emotional, social and physical) improved in both groups 
(p<0.05), with no difference between groups.  
Twenty coronary segments and 52 separate lesions in the AIT group, and 31 coronary 
segments and 92 separate lesions in the MCT groups were analyzed. Necrotic core was 
significantly reduced in both groups in distal coronary segments and in separate lesions with 
no evidence of a between-group difference. In distal segments, the median reduction was 3.2 
% in the AIT group and 2.7 % in the MCT group (both p<0.05). In separate lesions, the 
median reduction was -2.3 % when analyzing all lesions independently of intervention group 
(p<0.05), and -0.15 mm3 when lesions were clustered per patient (p<0.05). There was a strong 
trend toward a reduction in plaque burden independently of intervention group in separate 
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lesions. The reduction was -10.7 % (-21.7, 0.4, p=0.06). A minority of separate lesions (14.9 
%) underwent changes in terms of vulnerability during follow-up (Table 7). In 2 patients in 
the MCT group we observed that plaques transformed in either direction with respect to 
vulnerability within the same patient.  
 
Group and patient number Morphological pattern 
baseline 
Morphological pattern 
follow-up 
Increase or decrease in 
vulnerability 
AIT, patient#1 TCFA/CaTCFA PIT Decrease 
 TCFA/CaTCFA PIT Decrease 
 FA/CaFA FCa Decrease 
AIT, patient#5 FA/CaFA IMT Decrease 
AIT, patient#17 FCa PIT Decrease 
AIT, patient#33 TCFA/CaTCFA IMT Decrease 
MCT, patient#10 FCa TCFA/CaTCFA Increase  
 FCa TCFA/CaTCFA Increase 
 TCFA/CaTCFA IMT Decrease 
MCT, patient#15 TCFA/CaTCFA IMT Decrease 
 TCFA/CaTCFA PIT Decrease 
MCT, patient#18 TCFA/CaTCFA FA/CaFA Decrease 
MCT, patient#21 FCa TCFA/CaTCFA Increase  
MCT, patient#22 FA/CaFA PIT Decrease 
 FA/CaFA PIT Decrease 
MCT, patient#24 PIT TCFA/CaTCFA Increase  
 IMT PIT Increase  
MCT, patient#25 PIT IMT Decrease 
MCT, patient#37 PIT IMT Decrease 
 IMT PIT Increase  
MCT, patient#38 PIT IMT Decrease 
MCT, patient#41 PIT IMT Decrease 
Table 7. Separate lesions that underwent transformation during the study and were re-classified at follow-up. 
TCFA/CaTCFA; thin-capped fibroatheroma or calcified thin-capped fibroatheroma, FA/CaFA; fibroatheroma or 
calcified fibroatheroma, FCa; fibrocalcific, PIT; pathological imtimal thickening, IMT; intimal medial 
thickening.  
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In a sensitivity analysis on statin use, we compared changes in plaque burden and 
necrotic core between patients that used statins at study inclusion and patients that were given 
statins at baseline. The analysis was performed with and without inclusion of randomization 
group. There were no significant differences in the reduction of plaque burden and necrotic 
between the different statin groups (p<0.5 for all tests). 
 
4.2 Paper 2 “Clinical predictors of exercise-induced coronary plaque 
stabilization: A serial radiofrequency intravascular ultrasound study” 
The aim of the study was to assess baseline clinical variables that potentially were associated 
with an exercise-induced reduction in necrotic core volume or plaque burden in patients with 
established CAD undergoing PCI with stent implantation.  To assess this, data from the 
randomized controlled trial (Paper 1) was included (n=36). Random forest analysis followed 
by multivariate robust linear regression was used to identify potential predictors of beneficial 
exercise-induced changes in coronary plaques.     
When analyzing potential predictors of exercise-induced changes in coronary plaques, 
total cholesterol was the only variable associated with plaque burden reduction at follow-up in 
the random forest analysis, having a signal that was slightly stronger than random noise. In 
linear regression, the association between total cholesterol and plaque burden reduction was 
lost (p=0.33). Significant variables for necrotic core reduction were use of angiotensin 
enzyme inhibitors or angiotensin II receptor antagonist (weak signal), and clinical 
presentation (SCAD or NSTE-ACS) at baseline (strong signal). In linear regression, use of 
angiotensin enzyme inhibitors or angiotensin II receptor antagonist was not significant 
(p=0.41). Clinical presentation at baseline remained significantly associated with necrotic 
53 
 
core reduction (p=0.011). R-squared for the model including baseline clinical presentation 
and baseline necrotic core volume was 0.90.  
 The number of separate lesions per patient, plaque volume at baseline and necrotic 
core volume at baseline were comparable between the SCAD group and the NSTE-ACS 
group. The change in plaque volume at follow-up was -6.44 (-24.44;-1.77) mm3 in SCAD and 
-1.28 (-14.79;20.50) mm3 in NSTE-ACS (p=0.19). The change in necrotic core volume at 
follow-up was -4.94 (-10.33;-1.33) mm3 in SCAD and 1.03 (-4.29;3.71) mm3 in NSTE-ACS 
(p=0.01). The mean necrotic core volume at follow-up was 7.19 (1.87;13.14) mm3 higher in 
patients with NSTE-ACS compared to SCAD and necrotic core volume was reduced in 17 
patients (94 %) in the SCAD group compared to 8 patients (44 %) in the NSTE-ACS group 
(p=0.01, Figure 11).  
 
 
 
Statin use prior to study enrollment (> 6 months) and high-density lipoprotein 
cholesterol levels were the only clinical variables that differed between SCAD and NSTE-
Figure 11. 
Illustration of 
change in necrotic 
core volume at 
follow-up stratified 
by clinical 
presentation.  
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ACS patients at baseline (p<0.05). Fourteen of 18 patients with SCAD used statins prior to 
study inclusion compared to 5 of 18 patients in the NSTE-ACS group. High-density 
lipoprotein cholesterol was 1.4 (1.3-1.7) mmol/L and 1.1 (1.0-1.3) mmol/L in the SCAD and 
NSTE-ACS group, respectively. In a sensitivity analysis, neither statin use prior to study 
enrollment nor high-density lipoprotein cholesterol were significantly associated with the 
change in necrotic core volume or plaque burden (p>0.2 for all tests).  
 
4.3 Paper 3 “Reproducibility of grayscale and radiofrequency IVUS data 
acquisition in stented coronary arteries" 
The aim of the study was to assess inter-pullback reproducibility of volumetric GS- and RF-
IVUS data in stented coronary arteries. To achieve this, IVUS pullbacks were repeated in the 
same index artery at a single time-point, and agreements between these two pullbacks were 
examined.  
Fifteen patients (median age 55.2 years, 4 females) were included and examined with 
2 separate pullbacks. This resulted in a total of 30 pullbacks and 150 sub-segments for 
analysis. Inter-pullback reproducibility in GS-IVUS analysis for lumen volumes was very 
good for all segments with relative differences between pullbacks between ± 5 %. For vessel 
and plaque volumes, actual differences between pullbacks were low and relative differences 
were between ± 5 % for all non-stented segments and for the whole vessel. For stented 
segments, actual differences were somewhat larger, and the relative difference between 
pullbacks was 5.8 and 7.0 % for the vessel volume and plaque volume, respectively, thus 
indicating a weaker agreement than for non-stented segments.  
 In RF-IVUS analysis, inter-pullback reproducibility was generally poorer than in GS-
IVUS analysis. For RF-plaque volumes, the relative difference were large for the distal 
reference segment (-48.2 %) and the distal edge segment (-9.0 %), due to small plaque 
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volumes in these segments. The actual differences between pullbacks in these segments were 
comparable to the other segments. The relative difference in RF-plaque volume for the whole 
non-stented segment was -4.5 % corresponding to very good agreement.  
For plaque subtypes volumes, the actual differences were low and the relative 
differences were -5.3 % for fibrous, -7.0 % for fibro-fatty, 4.8 % for calcium and 2.4 % for 
necrotic core. Bland Altman plot for RF-plaque volume in the whole vessel is illustrated in 
Figure 12.  
 
 
Figure 12. Bland Altman plot displaying the inter-pullback reproducibility between pullbacks for RF-plaque 
volume in the whole non-stented vessel. The discontinued lines show limits of agreement. 
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Discussion 
  
The main findings in this thesis were the demonstration of a significant reduction in 
necrotic core and a strong trend towards a reduction of plaque burden in CAD patients 
following two different aerobic exercise protocols (Paper 1). These findings support that 
aerobic exercise has a direct effect on coronary atherosclerosis, not only with respect to 
atherosclerotic burden, but also with respect to the composition of coronary plaques and 
potentially also plaque vulnerability.  
Further, we found a strong association between the clinical presentation of CAD and 
necrotic core volume at follow-up. The association was in favor of patients with SCAD 
compared to NSTE-ACS patients (Paper 2). This finding supports that aerobic exercise may 
have a particular potential to induce beneficial changes in coronary atherosclerosis in SCAD 
patients compared to patients in the early phase following an ACS.   
Last, we demonstrated that the inter-pullback reproducibility of GS- and RF-IVUS is 
very good for non-stented coronary segments and acceptable for stented coronary segments. 
Furthermore, the reproducibility of IVUS parameters in non-stented segments seemed not to 
be influenced by the stent. These findings may be important for the design of future serial 
IVUS-studies in intervened vessels.   
The thesis presents data from one of the first studies that have assessed exercise-
induced effects on the coronary artery wall and coronary atherosclerosis by IVUS-based 
imaging modalities. To our knowledge, it is the first study in native coronary arteries that has 
used both GS- and RF-IVUS to assess the effects from aerobic exercise on coronary 
atherosclerosis, and the first IVUS exercise study that has included ACS patients. Although 
no randomized trial yet has demonstrated that aerobic exercise improves survival in CAD 
patients, several surrogate markers of cardiac or vascular function and functional capacity 
58 
 
improve following exercise. This thesis adds knowledge on the physiological adaptations that 
occur as a result of aerobic exercise in diseased coronary arteries in vivo.   
 
Aerobic exercise and atherosclerosis: disease burden versus plaque vulnerability 
For obvious reasons, studying coronary atherosclerosis in vivo in humans is not easy. Invasive 
imaging is required to obtain detailed plaque characteristics, and repeated procedures are 
necessary to assess effects from interventions or to study the natural history of disease. 
Therefore, animal models have been extensively used in previous research. Studies using 
hypercholesterolemic mice models have documented slowing of atherosclerosis progression 
following exercise 96. Pellegrin et al also found that exercise promoted plaque stabilization 118 
via increased fibrous cap thickness and decreased macrophage content in aortic plaques of 
swim-trained hypertensive Apo E-/- mice 119. This was demonstrated despite no improvement 
of cardiovascular risk factors, arguing for a direct effect from exercise on plaque phenotype.  
In humans, the easily accessible intima-media thickness measurment of the common 
carotid artery has been used as a marker of general atherosclerotic burden. Kadoglou et al 
found an association between physical inactivity and increased intima-media thickness 120, 
suggesting that physical activity may prevent progression of carotid atherosclerosis. In the 
coronary circulation, three previous trials have demonstrated a regression of diameter 
stenosis, evaluated by coronary angiography, in patients undergoing aerobic exercise 94,95,121. 
However, these results are limited by the fact that exercise was only one component of the 
life-style interventions given, and also by the general limitations of coronary angiography to 
assess atherosclerotic burden, such as underestimation of true disease severity due to diffuse 
coronary atherosclerosis or coronary remodeling 43.  
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Gielen et al stated in 2010 that “Surprisingly, not a single study has addressed 
exercise-mediated changes in plaque volume by intravascular ultrasound thus far to control 
the findings of the early regression studies with more accurate technique, which also permits 
insights into changes of plaque composition” 84. Since then, Sixt et al demonstrated an 
improvement of coronary endothelial function, but did not find an effect on plaque burden by 
GS-IVUS, comparing usual care to the combination of 4 weeks in-hospital exercise training 
with a hypocaloric diet in patients with type 2 diabetes 122. In heart transplant recipients, 
Nytroen et al found an attenuated progression of cardiac allograft vasculopathy, but no effect 
on necrotic core in patients that underwent AIT for one year 123. Although not directly 
comparable due to different pathophysiology in native and transplanted coronary arteries, this 
is in contrast to our findings, demonstrating a significant reduction in necrotic core both in 
patients undergoing MCT and AIT. The finding of reduced plaque burden as a result of 
exercise supports the conclusions from previous angiographic studies 94,95,121 and findings 
from animal exercise models 96,118,119 . The clinical implications of these findings are 
discussed later on. 
 
Exercise-induced plaque transformation 
Our predefined hypotheses stated that regular aerobic exercise would induce a general 
increase in endothelial shear stress, and that this would induce beneficial changes in coronary 
plaque geometry and composition. We also hypothesized that the increase in endothelial shear 
stress would be larger in subjects exercising with high intensity (AIT) compared to moderate 
intensity (MCT). Our main findings support the first of these hypotheses, but not the second, 
as the reduction in necrotic core and plaque burden were similar for patients undergoing the 
two different aerobic exercise protocols. As patients in both groups in our study demonstrated 
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improved aerobic fitness indicating a significant effect from exercise, it is plausible that this 
effect could influence coronary plaques through increased endothelial shear stress irrespective 
of exercise group. However, it needs to be emphasized that endothelial shear stress was not 
directly measured in our studies.  
Our findings of reduced plaque burden following aerobic exercise may support the 
findings from Koskinas et al, who demonstrated in a swine model that low endothelial shear 
stress promoted the initiation and progression of atherosclerotic plaques 91. These findings 
were also supported by the Prediction of Progression of Coronary Artery Disease and Clinical 
Outcome Using Vascular Profiling and Shear Stress and Wall Morphology (PREDICTION) 
study, demonstrating that coronary segments with the highest endothelial shear stress 
underwent the largest reductions in plaque burden 124.  
In terms of plaque vulnerability, previous studies assessing endothelial shear stress and 
plaque composition have shown conflicting results. Cheng et al used a perivascular shear 
stress modifier to induce changes in shear stress patterns in vivo (lowered, increased and 
lowered/oscillatory shear stress) in mouse carotid arteries 125. The main finding from this 
study was the demonstration of lowered endothelial shear stress inducing larger lesions with 
increased plaque vulnerability, whereas oscillatory shear stress regions induced stable lesions. 
A similar model, using computational fluid dynamics, was assessed in humans some years 
later when Samady et al studied endothelial shear stress in different coronary segments with 
respect to changes at 6 month follow-up 93. The investigators of this novel study found that 
high endothelial shear stress segments developed greater necrotic core and excessive 
expansive remodeling, suggestive of increased vulnerability, a conclusion in contrast to our 
hypothesis, and also the findings from Cheng et al 125. It should be emphasized that exercise-
induced changes in endothelial shear stress may have a relatively different effect in rodents 
than in large mammals 90, including humans, and it is therefore difficult to directly compare 
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the data from Cheng with our study and the study by Samady. Further exercise studies with 
measurement or estimation of changes in endothelial shear stress are needed to explore the 
discrepancies between the conclusions by Samady et al and our study.    
We observed that a minority of separate morphological lesions that were identified at 
baseline underwent transformation at follow-up with respect to plaque vulnerability (Table 7, 
page 45). Interestingly, we also observed that plaque transformation differed between separate 
lesions within the same patients. These observations are novel, and support that both systemic 
and local factors, such as intersegment differences in endothelial shear stress, may be 
involved in changes of plaque characteristics.  
  
Exercise and coronary atherosclerosis: stable versus unstable disease  
The rationale for performing a post-hoc analysis on the data from the randomized controlled 
trial was the following: AIT and MCT induced similar effects with respect to reduction of 
plaque burden and necrotic core in our study, and baseline clinical factors that may be 
associated with changes in these endpoints are unknown.  
We found that clinical presentation at study enrollment (i.e. SCAD versus NSTE-
ACS) was associated with necrotic core volume at follow-up in favour of patients with stable 
disease. The R-squared of the model including clinical presentation and baseline necrotic core 
volume was 0.90, suggesting that these two factors together explain most of the variability in 
necrotic core volume at follow-up. No other clinical variables were associated with exercise-
induced plaque burden reduction. Thus, our results may suggest that aerobic exercise post-
PCI has more beneficial effects in patients with SCAD compared to NSTE-ACS. 
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There are pathophysiological differences between stable and unstable coronary artery 
disease that could contribute to explaining our findings. Obstructive SCAD is characterized 
by plaques that have been growing progressively and slowly for many years 38. The total 
coronary inflammatory burden is lower than in unstable CAD and the fibrous cap is thick 126. 
This condition is rarely fatal, and presents clinically as angina pectoris. After decades of 
indolent progression of disease however, acute thrombosis leading to acute myocardial 
ischemia may occur in vulnerable plaques. This will most often present clinically as an ACS 
or sudden death. Such patients may present with multiple non-culprit vulnerable lesions 127 
corresponding to a high inflammatory burden in the coronary circulation. These vulnerable 
lesions are characterized by multi-focal and focal macrophage densities 128 which are not seen 
to a similar extent in patients with SCAD.  
Maybe even more important, some evidence also suggests that an acute event further 
accelerates coronary atherosclerosis. Dutta et al demonstrated that Apo e-/- mice developed 
larger and more advanced plaques following ACS via increased protease activity and 
monocyte recruitment from the bone marrow 129. The pro-inflammatory changes in these 
plaques persisted for several months, corresponding to the intervention period in our study. 
Although not assessed in humans, this may imply that post-ACS patients suffer from an 
increased pro-inflammatory load at the same time as these patients usually undergo cardiac 
rehabilitation.  
Based on our findings and the pathophysiological differences between SCAD and 
NSTE-ACS, it may be hypothesized that an increased pro-inflammatory load rendered 
patients with unstable disease in our study more resistant to exercise-induced plaque 
stabilization via decreased necrotic core volume at follow-up. In fact, 10 of 18 patients with 
NSTE-ACS demonstrated increased necrotic core volume at follow-up. It is also possible that 
exercise-induced effects on coronary atherosclerosis differ between stable and unstable 
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patients. Nevertheless, as almost every SCAD patient in our study demonstrated reduced 
necrotic core volume following aerobic exercise, this intervention may have an 
underestimated potential for plaque stabilization in stable patients. Whether aerobic exercise, 
through modification of coronary plaques, translates into reduced risk of coronary events in 
different coronary populations needs to be explored. It has to be emphasized that our results in 
Paper II should be considered hypothesis generating leaving more questions than definite 
answers. 
 
Procedural reproducibility in IVUS imaging 
When assessing inter-pullback reproducibility in diseased coronary arteries treated with stent 
implantation, we found that agreements between pullbacks using GS-IVUS were very good 
for non-stented segments (relative difference < 5 %), and poorer for stented segments (relative 
difference < 10 %). Furthermore, agreements between pullbacks using RF-IVUS (excluding 
the stented segment) were acceptable, but generally poorer than in GS-IVUS analyses. In RF-
plaque volume analysis, the relative difference between pullbacks was less than 5 % when 
analyzing the whole non-stented segment, corresponding to a very good agreement. 
 These findings add new knowledge regarding reproducibility in stented vessels, and 
also regarding reproducibility of IVUS parameters in non-stented segments of stented arteries, 
which seemed not to be influenced by the stent. Our conclusions support the previously 
reported data from non-intervened vessels. Rodriguez-Granillo et al. demonstrated very 
reproducible two-dimensional geometrical measurements, and found that RF-IVUS 
measurements were more variable than GS-variables 130. These findings were later reproduced 
by Prasad et al 59, and also by Hartmann et al 58, the latter using volumetric three-dimensional 
RF-IVUS. All of these studies found that the reproducibility for compositional measurements 
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(i.e. RF-data) were slightly poorer than for geometrical measurements (i.e. GS-data). The 
implications of our findings are discussed below. 
 
 Clinical implications 
Based on our findings in Paper 1, it seems probable that aerobic exercise has a potential to 
induce beneficial changes in coronary atherosclerosis that no previous intervention has been 
able to demonstrate by IVUS imaging. In fact, to date, no clinical intervention, including 
statin therapy131, has shown a significant reduction of coronary necrotic core volume in serial 
IVUS studies. Thus, our findings strengthen the scientific evidence for recommending aerobic 
exercise in CAD patients, and argue for increased use of exercise as medicine.   
Furthermore, the beneficial effects of aerobic exercise seem to be larger in patients 
with SCAD than in patients with NSTE-ACS (Paper 2). Thus, this non-pharmacological and 
easy accessible intervention may have an underestimated potential for plaque stabilization in 
the large SCAD population. It is very likely that exercise as effective medicine in this patient 
group is underused. 
It should be emphasized that the studies included in this thesis assessed exercise-
induced effects on previously diagnosed coronary atherosclerosis, and not general safety 
issues with respect to exercise in the general population. We experienced no adverse cardiac 
events during the study, but the sample size in our study was too small to assess cardiac safety 
issues with respect to AIT or MCT. However, with respect to CAD patients, a study from our 
group including over 175 000 training hours has demonstrated that aerobic exercise is safe, 
also in post-PCI patients undergoing exercise with high intensity 81.  
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One patient in the AIT group suffered from a cerebral hemorrhage approximately 36 
hours after completion of an AIT exercise session. Vigorous exercise has been identified as a 
possible trigger for rupture of cerebral aneurysms132; but the time span between exercise and 
the clinical event in our study makes increased blood pressure as a result from exercise an 
unlikely cause of hemorrhage in this particular case. Furthermore,  physical activity in general 
is associated with a decreased risk of cerebrovascular disease 133.  
The implications of our study on reproducibility (Paper 3) are probably most relevant 
to research and in clinical cases where repeated imaging is performed. Based on our data, 
future serial imaging studies in intervened vessels should account for a variability of 5-10 % 
attributed to the acquisition of images. Furthermore, the reproducibility of IVUS parameters 
in non-stented segments of stented coronary arteries seem not to be influenced by the stent 
itself. These findings may have implications for the design and power calculations in 
longitudinal studies using IVUS-based endpoints in stented coronary arteries.  
 
Limitations 
The use of IVUS-based imaging has obvious strengths such as the ability to visualize cross-
sectional images of coronary atherosclerosis. Furthermore, RF-IVUS is one of the few 
imaging modalities that has the ability to assess tissue components in coronary atheromas in 
vivo 44. On the other hand, IVUS-based imaging is also hampered with limitations that 
increase the uncertainty of the method, such as motion artefacts and ultrasound speckle 
imaging of blood cells in the artery lumen 134. The IVUS technique also assumes that the 
vessel is circular and that the catheter is located in the center of the artery with a transducer 
parallel to the long axis of the vessel. It is possible, however, that both transducer obliquity 
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and the curvature of the vessel can produce IVUS images that overestimate the dimensions of 
the vessel 135.  
Another important aspect of IVUS imaging is the analysis of data for research use. 
Dedicated software has been developed to help achieve correct data analysis, but there is still 
a need for substantial experience when correcting automatically drawn contours in every 
single frame of the IVUS pullback. Thus, a major strength of the studies included in this 
thesis is the use of very experienced analysts at an independent Core lab. 
 The studies included in this thesis are relatively small. However, the study designs 
with invasive procedures as part of the protocol mean obvious limitations and the number of 
patients included was equal to or higher than in several other exercise studies78-80,103,122. For 
the randomized controlled trial, no previous exercise trial with IVUS-based endpoints existed 
when power calculations were made. Thus, our study adds data for power calculations in 
future exercise studies using serial IVUS imaging.  
 The most important potential confounder in the randomized controlled trial was statin 
treatment, which was imbalanced between exercise groups at baseline. It can therefore be 
argued that this has confounded our results, both with respect to potential differences between 
groups, but also with respect to the mechanism for the beneficial effects on coronary 
atherosclerosis that was observed. However, in a sensitivity analysis, there were no 
differences in the reduction of necrotic core or plaque burden between different statin users, 
with and without inclusion of exercise group affiliation in the statistical model. Also, low-
density lipoprotein cholesterol and C-reactive protein levels were essentially unchanged at 
follow-up, indicating a modest statin effect during the study. It is therefore unlikely that the 
differences in statin use between exercise groups at baseline have confounded our results.   
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Future perspectives 
Several aspects of exercise-induced effects on coronary atherosclerosis still remain unknown, 
and the need for high-quality studies is obvious. In addition to confirming the results from this 
thesis, new studies need to address both general aspects of exercise as medicine in CAD 
patients, e.g. exercise modalities for different patient groups, duration of exercise, and the 
feasibility and adherence to exercise, as well as more specific issues related to exercise-
induced mechanisms in the artery wall. 
 The underlying mechanisms for plaque stabilization and reduced atherosclerotic 
burden as a result of exercise are still largely unknown. To assess these issues, one has to 
combine different methodology in well-designed clinical trials and also conduct relevant 
experimental studies. Furthermore, acknowledging that invasive imaging modalities have 
different strengths and limitations with respect to assessment of plaque volume and plaque 
composition, the combination of different imaging modalities such as IVUS, optical 
coherence tomography (OCT) and near-infrared-spectroscopy (NIRS) should be implemented 
in invasive study protocols.  
Another aspect of exercise in CAD patients is individual responses and also intra-
individual responses in the same patient. As hypothesized in Paper 2, it may be that aerobic 
exercise has different effects in different CAD patient groups. Furthermore, as demonstrated 
in Paper 1, some patients may experience different plaque effects in different coronary artery 
segments after an intervention period.  
To date, the concept of personalized medicine has to a little degree referred to the use 
of exercise as therapeutic medicine. Therefore, more knowledge of different responses in 
different patient groups, including clinical diagnosis, age, gender and co-morbidities, are 
needed.  
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An important factor is to motivate people to be more active in everyday life. Today, 
clinicians experience substantiated problems with patient adherence to exercise 
recommendations, and an increasing social gradient with respect to CVD risk factors has to be 
acknowledged. In many cases, a large number of practical obstacles need to be sorted out 
before patients start to exercise, and the many barriers to make patients to stay physically 
active in the long run are even more problematic. These challenges should also be addressed 
in future studies.   
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6 Conclusions 
 
a) In patients with significant CAD treated with stent implantation and optimal medical 
treatment, AIT or MCT for 12 weeks induced a strong trend towards a plaque burden 
reduction in separate morphological coronary lesions assessed by GS-IVUS. 
 
b) Using RF-IVUS, aerobic exercise induced a reduction in coronary necrotic core, both 
in distal coronary segments and in separate morphological lesions, by approximately 3 
% and 0.15 mm3, respectively.  
 
 
c) Reduction of coronary necrotic core volume in patients undergoing aerobic exercise 
was much more frequent in patients with SCAD than NSTE-ACS, and may be 
strongly dependent on the clinical and pathophysiological nature of coronary 
atherosclerosis.  
 
d) The inter-pullback reproducibility in stented coronary arteries was very good for GS-
data in non-stented segments with relative differences between pullbacks of < 5 %. 
The inter-pullback reproducibility was poorer for RF-data and GS-data in stented 
segments, but still acceptable with relative differences between pullbacks of < 10 %.  
 
 
 
  
70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
7 References  
 
1. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, 
Switzerland. World Health Organization, 2008. 
2. Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N 
Engl J Med 2012;366:54-63. 
3. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of 
coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 2010;35:72-
115. 
4. Wagner KH, Brath H. A global view on the development of non communicable diseases. 
Prev Med 2012;54 Suppl:S38-41. 
5. Fuster V, Kelly BB, Vedanthan R. Global cardiovascular health: urgent need for an 
intersectoral approach. J Am Coll Cardiol 2011;58:1208-1210. 
6. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, 
Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, 
Orenstein D, Wilson PW, Woo YJ, American Heart Association Advocacy Coordinating C, 
Stroke C, Council on Cardiovascular R, Intervention, Council on Clinical C, Council on E, 
Prevention, Council on A, Thrombosis, Vascular B, Council on C, Critical C, Perioperative, 
Resuscitation, Council on Cardiovascular N, Council on the Kidney in Cardiovascular D, 
Council on Cardiovascular S, Anesthesia, Interdisciplinary Council on Quality of C, 
Outcomes R. Forecasting the future of cardiovascular disease in the United States: a policy 
statement from the American Heart Association. Circulation 2011;123:933-944. 
7. Statistics Norway www.ssb.no. 
8. Jortveit J, Govatsmark RE, Digre TA, Risoe C, Hole T, Mannsverk J, Slordahl SA, 
Halvorsen S. Myocardial infarction in Norway in 2013. Tidsskr Nor Laegeforen 
2014;134:1841-1846. 
72 
 
9. Paffenbarger RS, Jr., Hyde RT. Exercise in the prevention of coronary heart disease. Prev 
Med 1984;13:3-22. 
10. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic 
disease. New perspectives based on the Framingham study. Ann Intern Med 1979;90:85-91. 
11. Eaker ED, Packard B, Thom TJ. Epidemiology and risk factors for coronary heart disease 
in women. Cardiovasc Clin 1989;19:129-145. 
12. Weintraub WS. Cigarette smoking as a risk factor for coronary artery disease. Adv Exp 
Med Biol 1990;273:27-37. 
13. Castelli WP. Diet, smoking, and alcohol: influence on coronary heart disease risk. Am J 
Kidney Dis 1990;16:41-46. 
14. Dale AC, Nilsen TI, Vatten L, Midthjell K, Wiseth R. Diabetes mellitus and risk of fatal 
ischaemic heart disease by gender: 18 years follow-up of 74,914 individuals in the HUNT 1 
Study. Eur Heart J 2007;28:2924-2929. 
15. Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. 
Am J Hypertens 1994;7:7s-12s. 
16. Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H. Risk factors for 
cardiovascular disease in Canada. Can J Cardiol 2003;19:1249-1259. 
17. Muller-Riemenschneider F, Nocon M, Willich SN. Prevalence of modifiable 
cardiovascular risk factors in German adolescents. Eur J Cardiovasc Prev Rehabil 
2010;17:204-210. 
18. Beltran-Sanchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of 
metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol 2013;62:697-
703. 
19. Giddens DP, Zarins CK, Glagov S. The role of fluid mechanics in the localization and 
detection of atherosclerosis. J Biomech Eng 1993;115:588-594. 
73 
 
20. Boyle PJ. Diabetes mellitus and macrovascular disease: mechanisms and mediators. Am J 
Med 2007;120:S12-17. 
21. Inoue T, Node K. Vascular failure: A new clinical entity for vascular disease. J Hypertens 
2006;24:2121-2130. 
22. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll 
Cardiol 1999;34:631-638. 
23. Veerasamy M, Bagnall A, Neely D, Allen J, Sinclair H, Kunadian V. Endothelial 
Dysfunction and Coronary Artery Disease: A State of the Art Review. Cardiol Rev 2014. 
24. Tiong AY, Brieger D. Inflammation and coronary artery disease. Am Heart J 
2005;150:11-18. 
25. Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med 
1999;107:85-97. 
26. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the 
pathogenesis of atherosclerosis. Circ Res 2002;91:281-291. 
27. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk 
plaque: part I: evolving concepts. J Am Coll Cardiol 2005;46:937-954. 
28. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. 
Curr Opin Lipidol 2003;14:421-430. 
29. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of 
novel risk factors: a clinicobiochemical perspective. Angiology 2007;58:513-522. 
30. Randolph GJ. Mechanisms that regulate macrophage burden in atherosclerosis. Circ Res 
2014;114:1757-1771. 
31. Mills CD. M1 and M2 Macrophages: Oracles of Health and Disease. Crit Rev Immunol 
2012;32:463-488. 
74 
 
32. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary 
syndromes: the pathologists' view. Eur Heart J 2013;34:719-728. 
33. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W, Jr., Richardson M, 
Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, et al. A definition of the intima of 
human arteries and of its atherosclerosis-prone regions. A report from the Committee on 
Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. 
Arterioscler Thromb 1992;12:120-134. 
34. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr., Rosenfeld ME, Schaffer SA, 
Schwartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate 
lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council 
on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1994;14:840-856. 
35. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Jr., Rosenfeld ME, 
Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic 
lesions and a histological classification of atherosclerosis. A report from the Committee on 
Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. 
Arterioscler Thromb Vasc Biol 1995;15:1512-1531. 
36. Schaar JA, Muller JE, Falk E, Virmani R, Fuster V, Serruys PW, Colombo A, Stefanadis 
C, Ward Casscells S, Moreno PR, Maseri A, van der Steen AF. Terminology for high-risk and 
vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 
18, 2003, Santorini, Greece. Eur Heart J 2004;25:1077-1082. 
37. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, 
Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger 
D, Bax JJ, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-
Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, 
Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, 
75 
 
Achenbach S, Badimon L, Bertrand M, Botker HE, Collet JP, Crea F, Danchin N, Falk E, 
Goudevenos J, Gulba D, Hambrecht R, Herrmann J, Kastrati A, Kjeldsen K, Kristensen SD, 
Lancellotti P, Mehilli J, Merkely B, Montalescot G, Neumann FJ, Neyses L, Perk J, Roffi M, 
Romeo F, Ruda M, Swahn E, Valgimigli M, Vrints CJ, Widimsky P. ESC Guidelines for the 
management of acute coronary syndromes in patients presenting without persistent ST-
segment elevation: The Task Force for the management of acute coronary syndromes (ACS) 
in patients presenting without persistent ST-segment elevation of the European Society of 
Cardiology (ESC). Eur Heart J 2011;32:2999-3054. 
38. Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, 
Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx 
N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R, Taggart DP, van der 
Wall EE, Vrints CJ, Guidelines ESCCfP, Zamorano JL, Achenbach S, Baumgartner H, Bax 
JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof 
P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, 
Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, 
Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-
Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James 
SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, 
Romeo F, Ryden L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, 
Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery 
disease: the Task Force on the management of stable coronary artery disease of the European 
Society of Cardiology. Eur Heart J 2013;34:2949-3003. 
39. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James 
S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar 
76 
 
JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, 
Taggart D. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-2555. 
40. Authors/Task Force m, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, 
Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, 
Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, 
Torracca L, Valgimigli M, Wijns W, Witkowski A, Authors/Task Force m. 2014 
ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial 
Revascularization of the European Society of Cardiology (ESC) and the European 
Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of 
the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart 
J 2014;35:2541-2619. 
41. Tavakol M, Ashraf S, Brener SJ. Risks and complications of coronary angiography: a 
comprehensive review. Global journal of health science 2012;4:65-93. 
42. Pijls NH, Tanaka N, Fearon WF. Functional assessment of coronary stenoses: can we live 
without it? Eur Heart J 2013;34:1335-1344. 
43. Nissen SE. Application of intravascular ultrasound to characterize coronary artery disease 
and assess the progression or regression of atherosclerosis. Am J Cardiol 2002;89:24B-31B. 
44. Garcia-Garcia HM, Costa MA, Serruys PW. Imaging of coronary atherosclerosis: 
intravascular ultrasound. Eur Heart J 2010;31:2456-2469. 
45. Garcia-Garcia HM, Gogas BD, Serruys PW, Bruining N. IVUS-based imaging modalities 
for tissue characterization: similarities and differences. Int J Cardiovasc Imaging 
2011;27:215-224. 
46. Baeroy SE, Nilsen GH, Vik-Mo H. [Intracoronary ultrasound in atherosclerotic disease 
and angioplasty]. Tidsskr Nor Laegeforen 2003;123:3193-3196. 
77 
 
47. Nair A, Kuban BD, Obuchowski N, Vince DG. Assessing spectral algorithms to predict 
atherosclerotic plaque composition with normalized and raw intravascular ultrasound data. 
Ultrasound Med Biol 2001;27:1319-1331. 
48. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque 
classification with intravascular ultrasound radiofrequency data analysis. Circulation 
2002;106:2200-2206. 
49. Nasu K, Tsuchikane E, Katoh O, Vince DG, Virmani R, Surmely JF, Murata A, Takeda 
Y, Ito T, Ehara M, Matsubara T, Terashima M, Suzuki T. Accuracy of in vivo coronary 
plaque morphology assessment: a validation study of in vivo virtual histology compared with 
in vitro histopathology. J Am Coll Cardiol 2006;47:2405-2412. 
50. Nair A, Margolis MP, Kuban BD, Vince DG. Automated coronary plaque characterisation 
with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention 2007;3:113-
120. 
51. Garcia-Garcia HM, Mintz GS, Lerman A, Vince DG, Margolis MP, van Es GA, Morel 
MA, Nair A, Virmani R, Burke AP, Stone GW, Serruys PW. Tissue characterisation using 
intravascular radiofrequency data analysis: recommendations for acquisition, analysis, 
interpretation and reporting. EuroIntervention 2009;5:177-189. 
52. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, 
McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW. A 
prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364:226-
235. 
53. Wilensky RL. In search of the elusive vulnerable plaque: reducing the gap between 
coronary imaging and necropsy findings. J Am Coll Cardiol 2013;61:1052-1053. 
54. Huisman J, Egede R, Rdzanek A, Bose D, Erbel R, Kochman J, Jensen LO, van der Palen 
J, Hartmann M, Mintz GS, von Birgelen C. Multicenter assessment of the reproducibility of 
78 
 
volumetric radiofrequency-based intravascular ultrasound measurements in coronary lesions 
that were consecutively stented. Int J Cardiovasc Imaging 2012;28:1867-1878. 
55. Regar E, Werner F, Klauss V, Siebert U, Henneke KH, Rieber J, Konig A, Theisen K, 
Mudra H. IVUS analysis of the acute and long-term stent result using motorized pullback: 
intraobserver and interobserver variability. Catheter Cardiovasc Interv 1999;48:245-250. 
56. Regar E, Werner F, Siebert U, Rieber J, Theisen K, Mudra H, Klauss V. Reproducibility 
of neointima quantification with motorized intravascular ultrasound pullback in stented 
coronary arteries. Am Heart J 2000;139:632-637. 
57. Blessing E, Hausmann D, Sturm M, Wolpers HG, Amende I, Mugge A. Intravascular 
ultrasound and stent implantation: intraobserver and interobserver variability. Am Heart J 
1999;137:368-371. 
58. Hartmann M, Mattern ES, Huisman J, van Houwelingen GK, de Man FH, Stoel MG, 
Danse PW, Louwerenburg HW, von Birgelen C. Reproducibility of volumetric intravascular 
ultrasound radiofrequency-based analysis of coronary plaque composition in vivo. Int J 
Cardiovasc Imaging 2009;25:13-23. 
59. Prasad A, Cipher DJ, Mohandas A, Roesle M, Brilakis ES, Banerjee S. Reproducibility of 
intravascular ultrasound virtual histology analysis. Cardiovascular revascularization 
medicine : including molecular interventions 2008;9:71-77. 
60. Korosoglou G, Giusca S, Gitsioudis G, Erbel C, Katus HA. Cardiac magnetic resonance 
and computed tomography angiography for clinical imaging of stable coronary artery disease. 
Diagnostic classification and risk stratification. Frontiers in physiology 2014;5:291. 
61. Kubo T, Tanaka A, Ino Y, Kitabata H, Shiono Y, Akasaka T. Assessment of Coronary 
Atherosclerosis using Optical Coherence Tomography. J Atheroscler Thromb 2014;21:895-
903. 
79 
 
62. Brugaletta S, Sabate M. Assessment of plaque composition by intravascular ultrasound 
and near-infrared spectroscopy: from PROSPECT I to PROSPECT II. Circ J 2014;78:1531-
1539. 
63. Shiroma EJ, Lee IM. Physical activity and cardiovascular health: lessons learned from 
epidemiological studies across age, gender, and race/ethnicity. Circulation 2010;122:743-752. 
64. Wisloff U, Nilsen TI, Droyvold WB, Morkved S, Slordahl SA, Vatten LJ. A single 
weekly bout of exercise may reduce cardiovascular mortality: how little pain for cardiac gain? 
'The HUNT study, Norway'. Eur J Cardiovasc Prev Rehabil 2006;13:798-804. 
65. Beaglehole R, Ebrahim S, Reddy S, Voute J, Leeder S, Chronic Disease Action G. 
Prevention of chronic diseases: a call to action. Lancet 2007;370:2152-2157. 
66. World Health Organization. The world health report 2002. Reducing risks, promoting 
healthy life. World Health Organization, Geneva, Switzerland. 2002. 
67. Al-Khalili F, Janszky I, Andersson A, Svane B, Schenck-Gustafsson K. Physical activity 
and exercise performance predict long-term prognosis in middle-aged women surviving acute 
coronary syndrome. J Intern Med 2007;261:178-187. 
68. Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ. 
Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. 
Circulation 2002;106:666-671. 
69. Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation 
post-myocardial infarction: a systematic review and meta-analysis of randomized controlled 
trials. Am Heart J 2011;162:571-584 e572. 
70. Naci H, Ioannidis JP. Comparative effectiveness of exercise and drug interventions on 
mortality outcomes: metaepidemiological study. BMJ 2013;347:f5577. 
71. Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS. Effects of physical activity on 
cardiovascular disease. Am J Cardiol 2012;109:288-295. 
80 
 
72. Wagner PD. New ideas on limitations to VO2max. Exerc Sport Sci Rev 2000;28:10-14. 
73. Mezzani A, Hamm LF, Jones AM, McBride PE, Moholdt T, Stone JA, Urhausen A, 
Williams MA, European Association for Cardiovascular P, Rehabilitation, American 
Association of C, Pulmonary R, Canadian Association of Cardiac R. Aerobic exercise 
intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the 
European Association for Cardiovascular Prevention and Rehabilitation, the American 
Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of 
Cardiac Rehabilitation. European journal of preventive cardiology 2013;20:442-467. 
74. Laursen PB, Jenkins DG. The scientific basis for high-intensity interval training: 
optimising training programmes and maximising performance in highly trained endurance 
athletes. Sports Med 2002;32:53-73. 
75. Moholdt TT, Amundsen BH, Rustad LA, Wahba A, Lovo KT, Gullikstad LR, Bye A, 
Skogvoll E, Wisloff U, Slordahl SA. Aerobic interval training versus continuous moderate 
exercise after coronary artery bypass surgery: a randomized study of cardiovascular effects 
and quality of life. Am Heart J 2009;158:1031-1037. 
76. Moholdt T, Aamot IL, Granoien I, Gjerde L, Myklebust G, Walderhaug L, Hole T, 
Graven T, Stolen T, Molmen-Hansen HE, Stoylen A, Skogvoll E, Slordahl SA, Wisloff U. 
Long-term follow-up after cardiac rehabilitation: a randomized study of usual care exercise 
training versus aerobic interval training after myocardial infarction. Int J Cardiol 
2011;152:388-390. 
77. Moholdt T, Aamot IL, Granoien I, Gjerde L, Myklebust G, Walderhaug L, Brattbakk L, 
Hole T, Graven T, Stolen TO, Amundsen BH, Molmen-Hansen HE, Stoylen A, Wisloff U, 
Slordahl SA. Aerobic interval training increases peak oxygen uptake more than usual care 
exercise training in myocardial infarction patients: a randomized controlled study. Clin 
Rehabil 2012;26:33-44. 
81 
 
78. Rognmo O, Hetland E, Helgerud J, Hoff J, Slordahl SA. High intensity aerobic interval 
exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients 
with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2004;11:216-222. 
79. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, 
Helgerud J, Slordahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen O, 
Skjaerpe T. Superior cardiovascular effect of aerobic interval training versus moderate 
continuous training in heart failure patients: a randomized study. Circulation 2007;115:3086-
3094. 
80. Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, Loennechen JP, Al-Share 
QY, Skogvoll E, Slordahl SA, Kemi OJ, Najjar SM, Wisloff U. Aerobic interval training 
versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. 
Circulation 2008;118:346-354. 
81. Rognmo O, Moholdt T, Bakken H, Hole T, Molstad P, Myhr NE, Grimsmo J, Wisloff U. 
Cardiovascular risk of high- versus moderate-intensity aerobic exercise in coronary heart 
disease patients. Circulation 2012;126:1436-1440. 
82. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 
2008;88:1009-1086. 
83. Linke A, Erbs S, Hambrecht R. Exercise and the coronary circulation-alterations and 
adaptations in coronary artery disease. Prog Cardiovasc Dis 2006;48:270-284. 
84. Gielen S, Schuler G, Adams V. Cardiovascular effects of exercise training: molecular 
mechanisms. Circulation 2010;122:1221-1238. 
85. Himburg HA, Dowd SE, Friedman MH. Frequency-dependent response of the vascular 
endothelium to pulsatile shear stress. Am J Physiol Heart Circ Physiol 2007;293:H645-653. 
86. Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells 
transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998;18:677-685. 
82 
 
87. Dhawan SS, Avati Nanjundappa RP, Branch JR, Taylor WR, Quyyumi AA, Jo H, 
McDaniel MC, Suo J, Giddens D, Samady H. Shear stress and plaque development. Expert 
review of cardiovascular therapy 2010;8:545-556. 
88. Papafaklis MI, Koskinas KC, Chatzizisis YS, Stone PH, Feldman CL. In-vivo assessment 
of the natural history of coronary atherosclerosis: vascular remodeling and endothelial shear 
stress determine the complexity of atherosclerotic disease progression. Curr Opin Cardiol 
2010;25:627-638. 
89. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of 
endothelial shear stress in the natural history of coronary atherosclerosis and vascular 
remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007;49:2379-
2393. 
90. Laughlin MH, Newcomer SC, Bender SB. Importance of hemodynamic forces as signals 
for exercise-induced changes in endothelial cell phenotype. J Appl Physiol 2008;104:588-600. 
91. Koskinas KC, Feldman CL, Chatzizisis YS, Coskun AU, Jonas M, Maynard C, Baker AB, 
Papafaklis MI, Edelman ER, Stone PH. Natural history of experimental coronary 
atherosclerosis and vascular remodeling in relation to endothelial shear stress: a serial, in vivo 
intravascular ultrasound study. Circulation 2010;121:2092-2101. 
92. Groen HC, Gijsen FJ, van der Lugt A, Ferguson MS, Hatsukami TS, Yuan C, van der 
Steen AF, Wentzel JJ. High shear stress influences plaque vulnerability Part of the data 
presented in this paper were published in Stroke 2007;38:2379-81. Netherlands heart journal 
: monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart 
Foundation 2008;16:280-283. 
93. Samady H, Eshtehardi P, McDaniel MC, Suo J, Dhawan SS, Maynard C, Timmins LH, 
Quyyumi AA, Giddens DP. Coronary artery wall shear stress is associated with progression 
83 
 
and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary 
artery disease. Circulation 2011;124:779-788. 
94. Niebauer J, Hambrecht R, Velich T, Hauer K, Marburger C, Kalberer B, Weiss C, von 
Hodenberg E, Schlierf G, Schuler G, Zimmermann R, Kubler W. Attenuated progression of 
coronary artery disease after 6 years of multifactorial risk intervention: role of physical 
exercise. Circulation 1997;96:2534-2541. 
95. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, 
Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ. Intensive lifestyle changes 
for reversal of coronary heart disease. JAMA 1998;280:2001-2007. 
96. Szostak J, Laurant P. The forgotten face of regular physical exercise: a 'natural' anti-
atherogenic activity. Clin Sci (Lond) 2011;121:91-106. 
97. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G. Effect 
of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J 
Med 2000;342:454-460. 
98. Adams V, Linke A, Krankel N, Erbs S, Gielen S, Mobius-Winkler S, Gummert JF, Mohr 
FW, Schuler G, Hambrecht R. Impact of regular physical activity on the NAD(P)H oxidase 
and angiotensin receptor system in patients with coronary artery disease. Circulation 
2005;111:555-562. 
99. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, 
Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal 
vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-
228. 
100. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche E, Bohm M, 
Nickenig G. Physical training increases endothelial progenitor cells, inhibits neointima 
formation, and enhances angiogenesis. Circulation 2004;109:220-226. 
84 
 
101. Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, Tarnok A, Gielen S, Emmrich F, 
Schuler G, Hambrecht R. Increase of circulating endothelial progenitor cells in patients with 
coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 
2004;24:684-690. 
102. Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training 
intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 2001;37:1891-
1900. 
103. Munk PS, Staal EM, Butt N, Isaksen K, Larsen AI. High-intensity interval training may 
reduce in-stent restenosis following percutaneous coronary intervention with stent 
implantation A randomized controlled trial evaluating the relationship to endothelial function 
and inflammation. Am Heart J 2009;158:734-741. 
104. Philipp S, Bose D, Wijns W, Marso SP, Schwartz RS, Konig A, Lerman A, Garcia-
Garcia HM, Serruys PW, Erbel R. Do systemic risk factors impact invasive findings from 
virtual histology? Insights from the international virtual histology registry. Eur Heart J 
2010;31:196-202. 
105. Machin D. Sample size tables for clinical studies. Blackwell science, 1997. 
106. Hiller A, Helvik AS, Kaasa S, Slordahl SA. Psychometric properties of the Norwegian 
MacNew Heart Disease health-related quality of life inventory. European journal of 
cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the 
European Society of Cardiology 2010;9:146-152. 
107. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, 
Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in 
humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 
2011;300:H2-12. 
85 
 
108. Harris RA, Nishiyama SK, Wray DW, Richardson RS. Ultrasound assessment of flow-
mediated dilation. Hypertension 2010;55:1075-1085. 
109. Mintz GS, Garcia-Garcia HM, Nicholls SJ, Weissman NJ, Bruining N, Crowe T, Tardif 
JC, Serruys PW. Clinical expert consensus document on standards for acquisition, 
measurement and reporting of intravascular ultrasound regression/progression studies. 
EuroIntervention 2011;6:1123-1130, 1129. 
110. Madssen E, Jakala J, Proniewska K, Kulaga T, Hegbom K, Wiseth R. Reproducibility of 
grayscale and radiofrequency IVUS data acquisition in stented coronary arteries. Scand 
Cardiovasc J 2014:1-18. 
111. Spencer T, Ramo MP, Salter DM, Anderson T, Kearney PP, Sutherland GR, Fox KA, 
McDicken WN. Characterisation of atherosclerotic plaque by spectral analysis of 
intravascular ultrasound: an in vitro methodology. Ultrasound Med Biol 1997;23:191-203. 
112. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden 
coronary death: a comprehensive morphological classification scheme for atherosclerotic 
lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275. 
113. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 
1982;14:377-381. 
114. Hausmann D, Erbel R, Alibelli-Chemarin MJ, Boksch W, Caracciolo E, Cohn JM, Culp 
SC, Daniel WG, De Scheerder I, DiMario C, et al. The safety of intracoronary ultrasound. A 
multicenter survey of 2207 examinations. Circulation 1995;91:623-630. 
115. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, 
Thompson DR, Oldridge N. Exercise-based rehabilitation for patients with coronary heart 
disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 
2004;116:682-692. 
86 
 
116. Hothorn T, Buhlmann P, Dudoit S, Molinaro A, van der Laan MJ. Survival ensembles. 
Biostatistics 2006;7:355-373. 
117. Strobl C, Malley J, Tutz G. An introduction to recursive partitioning: rationale, 
application, and characteristics of classification and regression trees, bagging, and random 
forests. Psychological methods 2009;14:323-348. 
118. Pellegrin M, Miguet-Alfonsi C, Bouzourene K, Aubert JF, Deckert V, Berthelot A, 
Mazzolai L, Laurant P. Long-term exercise stabilizes atherosclerotic plaque in ApoE 
knockout mice. Med Sci Sports Exerc 2009;41:2128-2135. 
119. Pellegrin M, Alonso F, Aubert JF, Bouzourene K, Braunersreuther V, Mach F, Haefliger 
JA, Hayoz D, Berthelot A, Nussberger J, Laurant P, Mazzolai L. Swimming prevents 
vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by 
modulating angiotensin II type 1 receptor expression independently from hemodynamic 
changes. Hypertension 2009;53:782-789. 
120. Kadoglou NP, Iliadis F, Liapis CD. Exercise and carotid atherosclerosis. Eur J Vasc 
Endovasc Surg 2008;35:264-272. 
121. Schuler G, Hambrecht R, Schlierf G, Niebauer J, Hauer K, Neumann J, Hoberg E, 
Drinkmann A, Bacher F, Grunze M, et al. Regular physical exercise and low-fat diet. Effects 
on progression of coronary artery disease. Circulation 1992;86:1-11. 
122. Sixt S, Beer S, Bluher M, Korff N, Peschel T, Sonnabend M, Teupser D, Thiery J, 
Adams V, Schuler G, Niebauer J. Long- but not short-term multifactorial intervention with 
focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 
2 and coronary artery disease. Eur Heart J 2010;31:112-119. 
123. Nytroen K, Rustad LA, Erikstad I, Aukrust P, Ueland T, Lekva T, Gude E, Wilhelmsen 
N, Hervold A, Aakhus S, Gullestad L, Arora S. Effect of high-intensity interval training on 
progression of cardiac allograft vasculopathy. J Heart Lung Transplant 2013;32:1073-1080. 
87 
 
124. Stone PH, Saito S, Takahashi S, Makita Y, Nakamura S, Kawasaki T, Takahashi A, 
Katsuki T, Namiki A, Hirohata A, Matsumura T, Yamazaki S, Yokoi H, Tanaka S, Otsuji S, 
Yoshimachi F, Honye J, Harwood D, Reitman M, Coskun AU, Papafaklis MI, Feldman CL. 
Prediction of progression of coronary artery disease and clinical outcomes using vascular 
profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION 
Study. Circulation 2012;126:172-181. 
125. Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, Krams 
R, de Crom R. Atherosclerotic lesion size and vulnerability are determined by patterns of 
fluid shear stress. Circulation 2006;113:2744-2753. 
126. Galon MZ, Wang Z, Bezerra HG, Lemos PA, Schnell A, Wilson DL, Rollins AM, Costa 
MA, Attizzani GF. Differences determined by optical coherence tomography volumetric 
analysis in non-culprit lesion morphology and inflammation in ST-segment elevation 
myocardial infarction and stable angina pectoris patients. Catheter Cardiovasc Interv 2014. 
127. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, 
Uemura S, Yu B, Mizuno K, Jang IK. Nonculprit plaques in patients with acute coronary 
syndromes have more vulnerable features compared with those with non-acute coronary 
syndromes: a 3-vessel optical coherence tomography study. Circulation Cardiovascular 
imaging 2012;5:433-440. 
128. MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H, Shishkov M, 
Kauffman CR, Houser SL, Aretz HT, DeJoseph D, Halpern EF, Tearney GJ. Focal and multi-
focal plaque macrophage distributions in patients with acute and stable presentations of 
coronary artery disease. J Am Coll Cardiol 2004;44:972-979. 
129. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, Iwamoto Y, 
Thompson B, Carlson AL, Heidt T, Majmudar MD, Lasitschka F, Etzrodt M, Waterman P, 
Waring MT, Chicoine AT, van der Laan AM, Niessen HW, Piek JJ, Rubin BB, Butany J, 
88 
 
Stone JR, Katus HA, Murphy SA, Morrow DA, Sabatine MS, Vinegoni C, Moskowitz MA, 
Pittet MJ, Libby P, Lin CP, Swirski FK, Weissleder R, Nahrendorf M. Myocardial infarction 
accelerates atherosclerosis. Nature 2012;487:325-329. 
130. Rodriguez-Granillo GA, Vaina S, Garcia-Garcia HM, Valgimigli M, Duckers E, van 
Geuns RJ, Regar E, van der Giessen WJ, Bressers M, Goedhart D, Morel MA, de Feyter PJ, 
Serruys PW. Reproducibility of intravascular ultrasound radiofrequency data analysis: 
implications for the design of longitudinal studies. Int J Cardiovasc Imaging 2006;22:621-
631. 
131. Raber L, Taniwaki M, Zaugg S, Kelbaek H, Roffi M, Holmvang L, Noble S, Pedrazzini 
G, Moschovitis A, Luscher TF, Matter CM, Serruys PW, Juni P, Garcia-Garcia HM, 
Windecker S, for the ITI. Effect of high-intensity statin therapy on atherosclerosis in non-
infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. Eur 
Heart J 2014. 
132. Vlak MH, Rinkel GJ, Greebe P, van der Bom JG, Algra A. Trigger factors and their 
attributable risk for rupture of intracranial aneurysms: a case-crossover study. Stroke 
2011;42:1878-1882. 
133. Lee IM, Paffenbarger RS, Jr. Physical activity and stroke incidence: the Harvard Alumni 
Health Study. Stroke; a journal of cerebral circulation 1998;29:2049-2054. 
134. Yeom E, Nam KH, Paeng DG, Lee SJ. Effects of red blood cell aggregates dissociation 
on the estimation of ultrasound speckle image velocimetry. Ultrasonics 2014;54:1480-1487. 
135. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, 
Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG. American College of Cardiology Clinical 
Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of 
Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology 
Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37:1478-1492. 
 
  
Paper I 
 
 
 
 
 
 
 
 
 
 
 
Coronary Atheroma Regression and Plaque Characteristics
Assessed by Grayscale and Radiofrequency Intravascular
Ultrasound After Aerobic Exercise
Erik Madssen, MDa,b,*, Trine Moholdt, PhDa,c,d, Vibeke Videm, MD, PhDe,f, Ulrik Wisløff, PhDa,c,
Knut Hegbom, MDb, and Rune Wiseth, MD, PhDa,b
The aim of the present study was to investigate effects of aerobic interval training (AIT)
versus moderate continuous training (MCT) on coronary atherosclerosis in patients with
signiﬁcant coronary artery disease on optimal medical treatment. Thirty-six patients were
randomized to AIT (intervals atz 90% of peak heart rate) or MCT (continuous exercise at
z 70% of peak heart rate) 3 times a week for 12 weeks after intracoronary stent implan-
tation. Grayscale and radiofrequency intravascular ultrasounds (IVUS) were performed at
baseline and follow-up. The primary end point was the change in plaque burden, and the
secondary end points were change in necrotic core and plaque vulnerability. Separate le-
sions were classiﬁed using radiofrequency IVUS criteria. We demonstrated that necrotic
core was reduced in both groups in deﬁned coronary segments (AITL3.2%, MCTL2.7%,
p <0.05) and in separate lesions (median changeL2.3% andL0.15 mm3, p <0.05). Plaque
burden was reduced by 10.7% in separate lesions independent of intervention group
(p [ 0.06). No signiﬁcant differences in IVUS parameters were found between exercise
groups. A minority of separate lesions were transformed in terms of plaque vulnerability
during follow-up with large individual differences between and within patients. In
conclusion, changes in coronary artery plaque structure or morphology did not differ
between patients who underwent AIT or MCT. The combination of regular aerobic exercise
and optimal medical treatment for 12 weeks induced a moderate regression of necrotic core
and plaque burden in IVUS-deﬁned coronary lesions.  2014 Elsevier Inc. All rights
reserved. (Am J Cardiol 2014;114:1504e1511)
Physical activity is associated with reduced mortality risk
in patients with coronary artery disease (CAD).1 Aerobic
capacity is also found to be a strong predictor of mortality in
patients with CAD.2 The mechanisms responsible for the
favorable effects of exercise are not completely understood
and may include both modiﬁcation of cardiovascular risk
factors3 and a direct effect on atherosclerosis.4 It is hypoth-
esized that increased endothelial shear stress (ESS) produced
by bouts of exercise acts antiatherogenically through the
modulation of endothelial cell phenotypes.5 However, high
ESS produced by exercise may also increase vulnerability in
established plaques,6 possibly leading to coronary events.7
Three previous trials have documented favorable effects of
exercise on CAD evaluated by coronary angiography.8e10
However, there is a paucity of data demonstrating effects
of exercise on coronary atherosclerosis evaluated by intra-
vascular ultrasound (IVUS).11 In the present study, we
assessed the effects of 2 different aerobic exercise protocols
on coronary plaque structure and morphology in patients
with CAD using grayscale intravascular ultrasound
(GS-IVUS) and radiofrequency intravascular ultrasound
(RF-IVUS).
Methods
This was a single-center, open, parallel, randomized
controlled trial. The study protocol was approved by the
Regional Ethics Committee of Central Norway (2010/1112),
registered at theClinicalTrials.gov (identiﬁer NCT01228201)
and performed according to the Declaration of Helsinki.
Written informed consent was obtained from all participants.
Forty-one patients with angina pectoris or non-ST elevation
acute coronary syndrome treated with stent implantation were
found eligible and enrolled in the study from December 2010
to April 2012. An overview of the study, including the
exclusion criteria, is presented in Figure 1. All patients
received standard in-hospital care and optimal medical treat-
ment according to the current guidelines. After baseline data
acquisition, patients were randomized to aerobic interval
training (AIT, 19 patients) or moderate continuous training
(MCT, 22 patients) by block randomization using a
aDepartment of Circulation and Medical Imaging, cK. G. Jebsen Center
of Exercise in Medicine, and fDepartment of Laboratory Medicine,
Children’s and Women’s Health, Norwegian University of Science and
Technology, Trondheim, Norway; and bDepartment of Cardiology,
dWomen’s Clinic, and eDepartment of Immunology and Transfusion
Medicine, St. Olavs Hospital, Trondheim, Norway. Manuscript received
June 3, 2014; revised manuscript received and accepted August 15, 2014.
The study was funded by The Liaison Committee for Central Norway
Regional Health Authority and the Norwegian University of Science and
Technology, the Research Fund at St. Olavs University Hospital, the
Norwegian Council on Cardiovascular Disease, and the Norwegian Council
for Public Health.
See page 1510 for disclosure information.
*Corresponding author: Tel: (0047) 728-28-140; fax: (0047) 728-28-
372.
E-mail address: erik.madssen@ntnu.no (E. Madssen).
0002-9149/14/$ - see front matter  2014 Elsevier Inc. All rights reserved. www.ajconline.org
http://dx.doi.org/10.1016/j.amjcard.2014.08.012
Web-based randomization tool. Data acquisition was repeated
at follow-up 2 to 3 days after completed intervention.
An individually adjusted cardiopulmonary exercise test
was performed on treadmills (Woodway PPS55, Weil am
Rhein, Germany), and gas exchange data were analyzed
(Oxycon Pro; Jaeger, Hoechberg, Germany). Peak oxygen
uptake (VO2peak) was calculated as the mean of the 3 highest
VO2 measurements during the test. The highest heart rate
(HR) during the test was recorded as peak HR, and HR
recovery was deﬁned as the change in peak HR to HR after
1 minute of rest. Subjective perception of exertion was
assessed using the Borg 6-20 scale.
Figure 1. Flow diagram of enrollment, randomization, follow-up, and data analyses. Other: Previous surgical revascularization (n ¼ 53), arrhythmias including
atrial ﬁbrillation (n ¼ 40), lack of consent to participate (n ¼ 14), coronary artery anatomy not suitable for IVUS (n ¼ 13), planned surgery within 4 months
(n ¼ 11), or inclusion in another randomized trial (n ¼ 9). CABG ¼ coronary artery bypass grafting.
Figure 2. Schematic drawing of analyzed coronary artery segments. Data from the proximal and distal reference segments were included in the present study.
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All patients exercised on treadmills 3 times a week for
12 weeks with attendance  90% of sessions in all patients.
Training sessions were supervised by experienced staff, and
patients used HR monitors (Polar Electro, Kempele,
Finland) to help achieve target HR during exercise. The AIT
program was based on previous protocols from our research
group12e14 and consisted of 10 minutes of warm-up fol-
lowed by intervals of 4 times 4 minutes, with an active
pause of 3-minute in-between intervals and at the end. The
target HR was 85% to 95% of the peak HR during intervals
and 70% of peak HR in the active pause. The MCT program
was isocaloric to the AIT program15 and consisted of
continuous walking or light running for 46 minutes at 70%
of maximum HR.
Quality of life parameters were assessed by the MacNew
Heart Disease Health-Related Quality of Life Questionnaire.
A fasting venous blood sample was analyzed for glucose,
total cholesterol, low-density lipoprotein cholesterol, high-
density lipoprotein cholesterol, triglycerides, glycosylated
hemoglobin, N-terminal pro-brain natriuretic peptide, and
C-reactive protein. Endothelial-dependent vasodilation in
the brachial artery was estimated by ﬂow-mediated vasodi-
lation (FMD) according to guidelines16 using a 12-MHz
Doppler Probe (Vivid 7 System; GE Vingmed Ultrasound,
Horten, Norway). Images were analyzed by an independent
observer using an automatic edge detection software
(Vascular Research Tools 5; Medical Imaging Applications
LLC, Coralville, IA). The percentage FMD normalized for
shear rate was reported.
Coronary angiography and percutaneous coronary inter-
vention with stent implantation were performed in accordance
with international guidelines. Drug-eluting stents (Xience
Everolimus Eluting Stents, Abbot Vascular, Santa Clara, CA or
Resolute Integrity Zotarolimus Eluting Stents, Medtronic Inc,
Minneapolis, MN) were used in all patients except 4 (1 in the
AIT group and 3 in the MCT group) who received bare metal
stents (Integrity, Medtronic Inc). GS- and RF-IVUS were per-
formed without complications, after intracoronary administra-
tion of 200 mg of nitroglycerin, using the Eagle Eye Platinum
IVUS 20 MHz probe (Volcano Corporation, Rancho Cordova,
CA) with a pullback rate of 0.5 mm/s (Volcano R100 pullback
device). RF backscatter data were collected with a dedicated
console (Volcano Corporation) at every R-peak on the elec-
trocardiogram. The IVUS probe was advanced as far distally as
possible and >10 mm beyond the distal stent edge, and pull-
backswere continued through the stented region andproximally
into the ostium of the index artery. Data were stored digitally
for analyses at an independent core laboratory (Krakow
Cardiovascular Research Institute, Krakow, Poland). All ana-
lysts were blinded to clinical data and randomization group.
Intravascular data were analyzed (QIvus software 2.1;
Medis Medical Imaging Systems, Leiden, The Netherlands)
by automatic contour detection of lumen and vessel according
to current recommendations.17,18 The analyst optimized
contours through image characteristic settings and compared
the correctness of each edge of automatically drawn contours.
Matched coronary segments at baseline and follow-up were
identiﬁed using ﬁduciary points, such as side braches and the
implanted stent. Parts of segments that were not visible in
both pullbacks were excluded. Two regions of interest were
deﬁned in the analytic plan: the distal segment, starting
distally as far as possible to 5 mm from the distal stent edge,
and the proximal segment, starting 5 mm from the proximal
stent edge to as far proximally as possible (Figure 2). The
following GS-IVUS parameters were computed: minimal
lumen area, plaque burden (plaque plus media area divided by
the vessel area), total atheroma volume (cross-sectional area
of external elastic membrane minus cross-sectional area of
lumen) normalized for segment length, and remodeling index
(cross-sectional area of external elastic membrane at minimal
lumen area divided by the cross-sectional area of external
elastic membrane at the smallest plaque burden). The
RF-IVUS parameters were computed based on spectral
analysis of the backscattered RF data. Absolute volumes and
percentage volumes of ﬁbrous, ﬁbro-fatty, necrotic core, and
dense calcium components were analyzed (data not shown
for other tissue components than necrotic core).
Table 1
Baseline characteristics of the study population
Variable Aerobic
Interval
Training
(n ¼ 15)
Moderate
Continuous
Exercise
(n ¼ 21)
Age (years) 55.5 (50e60.5) 60.5 (56.5e63.5)
Male/female 14/1 15/6
Current smoker 3 (20%) 3 (14%)
Hypertension 8 (53%) 12 (57%)
Diabetes mellitus 5 (33%) 3 (14%)
Hypercholesterolemia 4 (27%) 7 (33%)
Prior myocardial infarction 1 (7%) 4 (19%)
Prior percutaneous coronary
intervention
3 (20%) 5 (24%)
Current diagnosis
Angina pectoris 7 (47%) 11 (52%)
NSTE-ACS 8 (53%) 10 (48%)
No. of coronary arteries narrowed
1 11 (73%) 13 (62%)
2 3 (20%) 8 (38%)
3 1 (7%) 0 (0%)
Target coronary artery location
Left ascending 9 (60%) 10 (48%)
Circumﬂex 2 (13%) 4 (19%)
Right 4 (27%) 7 (33%)
Segments assessed
Distal to the stent 11 17
Proximal to the stent 9 14
Segment lengths (mm)
Distal to the stent 14.1 (7.1e22.0) 25.0 (19.2e31.6)*
Proximal to the stent 13.5 (7.5e23.0) 15.2 (9.8e20.7)
Identiﬁed separate lesions 52 (36%) 92 (64%)
Medication
Aspirin 15 (100%) 21 (100%)
Clopidogrel 15 (100%) 21 (100%)
Statins 15 (100%) 21 (100%)
Simvastatin 40 mg 12 (80%) 15 (71%)
Atorvastatin 40 mg 3 (20%) 6 (29%)
Beta blockers 12 (80%) 15 (71%)
ACE enzyme inhibitors or
angiotensin II receptor
antagonists
8 (53%) 11 (52%)
Note: Data are given as numbers with percentages or medians with 95%
conﬁdence intervals in parenthesis.
* Signiﬁcant difference between groups (p <0.05).
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Morphologic patterns were classiﬁed18 by identifying
plaques with a plaque burden >40% over 3 consecutive
frames separated by 5 mm lengths of artery with a plaque
burden <40% (deﬁned as separate lesions). Separate lesions
were classiﬁed according to the American Heart Association
histological classiﬁcation19 adapted for RF-IVUS and in
Table 3
Cardiorespiratory variables at baseline and follow-up
Aerobic Interval Training Moderate Continuous Training
Baseline Follow-Up Baseline Follow-Up
Resting heart rate (beats/min) 61 (56e65) 58 (52e63) 58 (54e63) 59 (55e63)
Peak heart rate (beat/min) 158 (150e167) 162 (154e169) 155 (146e164) 158 (148e168)
Heart rate recovery, 1 minute 29 (24e33) 30 (26e36) 27 (24e31) 27 (24e31)
Peak oxygen uptake (mL*kg1*min1) 31.2 (29.1e34) 34.5 (32.3e37.9)*† 29.8 (27.5e33.7) 31.8 (29.1e35.4)*
Peak oxygen uptake (mL*min1) 2750 (2423e2954) 3084 (2730e3385)*† 2545 (2146e2888) 2722 (2307e3101)*
Respiratory exchange ratio at peak oxygen uptake 1.12 (1.09e1.14) 1.12 (1.10e1.15) 1.11 (1.09e1.14) 1.11 (1.09e1.13)
Borg scale at peak oxygen uptake 17 (16e17) 18 (17e18) 17 (16e18) 18 (17e18)
Note: Data are given as medians with 95% conﬁdence intervals in parenthesis.
* Signiﬁcant within-group difference from baseline to follow-up (p <0.05).
† Signiﬁcant between-group difference from baseline to follow-up (p <0.05).
Table 4
Grayscale and radiofrequency intravascular ultrasound data at baseline and follow-up in segments proximal and distal to the implanted stent
Aerobic Interval Training Moderate Continuous Training
Baseline Follow-Up Baseline Follow-Up
Proximal segments
Minimal lumen area (mm2) 6.07 (5.25e8.13) 5.99 (4.90e7.16) 6.08 (4.59e7.92) 5.82 (4.20e7.49)
Total atheroma volume† (mm3) 9.10 (5.40e22.60) 8.30 (5.30e26.10) 10.70 (6.10e37.50) 10.10 (6.20e39.8)
Plaque burden (%) 50.7 (42.8e59.0) 51.9 (40.5e59.8) 48.8 (39.5e55.3) 48.3 (42.0e56.6)
Remodeling index 0.97 (0.86e1.18) 1.02 (0.95e1.16) 0.94 (0.87e1.01) 0.93 (0.86e0.99)
Necrotic core volume (mm3) 24.6 (9.3e42.8) 23.3 (7.0e40.4) 16.5 (4.2e27.0) 13.7 (6.2e42.8)
Necrotic core volume (%) 22.6 (17.3e29.2) 20.9 (15.2e30.8) 18.4 (14.8e22.0) 18.5 (13.7e22.6)
Distal segments
Minimal lumen area (mm2) 5.14 (4.24e6.75) 4.78 (4.10e8.07) 4.77 (3.95e5.58) 5.24 (4.28e6.14)
Total atheroma volume† (mm3) 3.96 (1.95e8.06) 3.70 (1.69e7.43) 6.96 (4.08e10.32) 6.53 (3.93e10.42)
Plaque burden (%) 30.7 (23.5e38.7) 28.4 (22.8e38.2) 40.4 (33.9e46.8) 38.4 (32.6e45.1)
Remodeling index 0.88 (0.78e0.98) 0.95 (0.83e1.10) 0.94 (0.86e1.02) 0.98 (0.90e1.04)
Necrotic core volume (mm3) 3.2 (0.1e12.5) 2.1 (0e11.6) 18.4 (5.0e31.6) 10.7 (3.6e23.6)
Necrotic core volume (%) 17.9 (9.6e23.7) 14.7* (6.2e20.7) 18.6 (14.0e23.2) 15.9* (11.7e19.2)
Note: Data are given as medians with 95% conﬁdence intervals in parenthesis.
* Signiﬁcant within-group difference from baseline to follow-up (p <0.05).
† Normalized for segment length.
Table 2
Anthropometric data, biomarkers, and ﬂow-mediated vasodilation at baseline and follow-up
Aerobic Interval Training Moderate Continuous Exercise
Baseline Follow-Up Baseline Follow-Up
Body mass index (kg/m2) 27.3 (25.3e29.4) 27.4 (25.6e29.2) 26.3 (24.7e28.3) 26.3 (24.5e28.3)
Waist circumference (cm) 100 (93e104) 100 (92e102) 100 (94e104) 97 (92e102)
C-reactive protein (mg/L) 3.65 (1.55e5.93) 2.30 (1.35e3.63) 2.57 (1.59e3.75) 1.93 (1.17e3.9)
N-terminal pro-brain natriuretic peptide (ng/L) 65 (45e161) 67 (28e199) 189 (104e372) 118 (75e207)
Glucose (mmol/L) 5.8 (5.5e7.2) 6.0 (5.5e6.9) 5.8 (5.5e6.2) 5.8 (5.5e6.3)
Glycosylated hemoglobin (%) 5.8 (5.5e7.1) 5.8 (5.5e6.5) 5.9 (5.7e6.2) 5.8 (5.6e6.1)
Total cholesterol (mmol/L) 4.3 (3.8e4.6) 4.2 (3.7e4.7) 4.4 (4.2e4.6) 4.4 (4.2e4.7)
LDL-cholesterol (mmol/L) 2.4 (2.2e2.7) 2.2 (2.0e2.6) 2.4 (2.2e2.7) 2.3 (2.2e2.5)
HDL-cholesterol (mmol/L) 1.2 (1.0e1.4) 1.2 (1.1e1.4) 1.3 (1.1e1.5) 1.4 (1.2e1.6)
Triglycerides (mmol/L) 1.1 (0.9e1.9) 1.2 (1.0e1.7) 1.2 (1.0e1.5) 1.3 (1.0e1.8)
Flow-mediated vasodilation (%) 8.4 (5.2e12.1) 11.3 (7.3e16.7) 11.9 (7.2e17.0) 15.1 (9.8e24.6)
Note: Data are given as medians with 95% conﬁdence intervals in parenthesis. No signiﬁcant differences within or between groups.
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terms of vulnerability18 in the following order: intimal
medial thickening, pathologic intimal thickening, ﬁbrotic or
ﬁbrocalciﬁc, ﬁbroatheroma or calciﬁed ﬁbroatheroma, and
thin-capped ﬁbroatheroma (TCFA) or calciﬁed thin-capped
ﬁbroatheroma (CaTCFA), with TCFA or CaTCFA being
highest risk plaques. Inter- and intraobserver variability for
RF-IVUS analyses (performed on 221 regions of interest)
showed good to excellent correlation between 2 different
analysts and for a single analyst (k ¼ 0.79 and k ¼ 1,
respectively).
The primary end point was deﬁned as change in plaque
burden for the proximal and distal coronary segment and for
separate lesions. The secondary end points were deﬁned as
change in necrotic core for the proximal and distal coronary
segment and for separate lesions and change in plaque
vulnerability for separate lesions. Data were analyzed using
SPSS (version 20.0; IBM, Chicago, IL), Stata (version 12.1;
StataCorp, College Station, TX), and Minitab (version
16.2.1; Minitab, State College, PA). Data are given as fre-
quencies and percentages or medians with 95% conﬁdence
intervals in parenthesis because many variables were not
normally distributed. Baseline characteristics were compared
using the chi-square test or Mann-Whitney U test. Data
measured twice were analyzed using repeated measures
analysis of variance and linear mixed models with maximum
likelihood estimation. Where appropriate, plaques in each
patient were clustered by patient number. Variables were
logarithmically transformed if necessary to achieve adequate
model ﬁt. p values <0.05 were considered statistically
signiﬁcant.
Results
One patient in the AIT group was excluded because of a
cerebral hemorrhage. Otherwise, there were no adverse
events in the study. Furthermore, 3 patients did not complete
intervention, and data from 1 patient were not possible to
analyze (Figure 1).
Baseline clinical characteristics are given in Table 1.
The distal segment length was longer in the MCT group
(p <0.05), and therefore, total atheroma volume was
normalized for segment length in the analyses as recom-
mended.17 Twelve patients in the AIT group and 7 patients
in the MCT group had used statins for >6 months before
study inclusion (difference between groups, p <0.05).
Otherwise, statins were initiated at the time of admission 
1 day. To account for potential confounding from differ-
ences in statin use, changes in plaque burden and necrotic
core were calculated between the different categories of
statin users, with and without inclusion of exercise group
afﬁliation. There were no differences in the reduction of
necrotic core or plaque burden between the different statin
groups in any analyses (data not shown, p >0.5 for all tests).
Table 2 presents anthropometric data, biomarkers, and
FMD. There was a trend for improvement in FMD in both
groups (p ¼ 0.07), with no difference between groups.
Quality of life parameters (emotional, physical, and social
domains) improved in both groups (p <0.05), with no dif-
ference between groups (data not shown). VO2peak improved
in both groups (p <0.001), and the improvement was larger
in the AIT group (p <0.05, Table 3).
Twenty coronary segments and 52 separate lesions in the
AIT group and 31 coronary segments and 92 separate le-
sions in the MCT group were analyzed (Table 4). Necrotic
core was signiﬁcantly reduced, independent of intervention
group, both in separate lesions and in distal coronary seg-
ments. In separate lesions, the median reduction was 2.3%
(4.4, 0.3) when analyzing all lesions (p <0.05)
and0.15 mm3 (0.04,0.27) when lesions were clustered
per patient (p <0.05). There was a strong trend toward a
reduction in plaque burden of 10.7% (21.7, 0.4) inde-
pendent of intervention group in separate lesions (p ¼ 0.06).
Separate lesions at baseline (AIT/MCT, respectively)
were classiﬁed as 16 of 21 intimal medial thickenings, 1 of
14 pathologic intimal thickening, 5 of 6 ﬁbrocalciﬁcs, 6 of
10 FAs/CaFAs, and 24 of 41 TCFAs/CaTCFAs. A minority
of lesions (14.9%) changed in terms of plaque vulnerability
during follow-up (Figure 3). All 6 lesions in the AIT group
that were reclassiﬁed were transformed into less vulnerable
lesions (Figures 4 and 5). In the MCT group, 10 lesions
were transformed into less vulnerable lesions (Figure 5), and
6 lesions were transformed into more vulnerable lesions. In
Figure 3. Classiﬁcation of separate lesions at follow-up stratiﬁed by exer-
cise group. Axis shows number of lesions.
Figure 4. Separate lesions that underwent transformation during the study
and that were reclassiﬁed at follow-up (14.9% of all separate lesions).
Vertical axis shows lesion type with increased vulnerability along the axis,
and horizontal axis shows patient study number. FA/CaFA ¼ ﬁbroatheroma
or calciﬁed ﬁbroatheroma; FCa ¼ ﬁbrocalciﬁc; IMT ¼ intimal medial
thickening; PIT ¼ pathologic intimal thickening; TCFA/CaTCFA ¼
thin-capped ﬁbroatheroma or calciﬁed thin-capped ﬁbroatheroma.
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3 patients in the MCT group (patient numbers 10, 24, and
37, Figure 4), we observed that plaques transformed in
either direction with respect to vulnerability within the same
patient.
Discussion
We assessed the effects of 2 different aerobic exercise
programs on coronary atherosclerosis evaluated by GS- and
RF-IVUS. Changes in coronary artery plaque structure and
morphology did not differ between patients who underwent
AIT or MCT. The combination of regular aerobic exercise
and optimal medical treatment for 12 weeks induced a
moderate regression of plaque burden and necrotic core in
IVUS-deﬁned coronary lesions.
More than 30 years ago, it was demonstrated that exer-
cise prevented CAD in monkeys that were on an atherogenic
diet.20 Since then, other animal studies have also supported
that exercise has antiatherogenic effects.21,22 However,
direct evidence of such effects in humans is difﬁcult to
obtain. In 3 previous trials, a regression of diameter stenosis
evaluated by coronary angiography was found in patients
who underwent exercise training.8e10 To our knowledge,
only 1 previous study has evaluated exercise-induced effects
on native CAD with IVUS in humans. In this study, using a
multifactorial intervention program and not including
assessment of plaque composition, there was no evidence of
reduced plaque burden in the intervention group.11
We found a strong trend toward a 10% reduction in
plaque burden in IVUS-deﬁned separate lesions with no
evidence of a difference between exercise groups, despite a
larger increase in VO2peak in the AIT group. A possible
explanation for this observation could be that the introduc-
tion of regular exercise in most patients represented a major
intervention and change in lifestyle irrespective of exercise
protocol. One may speculate that a prolonged intervention
period could have induced larger reductions in plaque
burden and revealed differences between groups.
It is hypothesized that increased ESS, induced by
increased coronary blood ﬂow produced by bouts of exercise,
is responsible for an antiatherogenic effect through alterna-
tions of multiple gene expression in endothelial cells.5
Koskinas et al23 demonstrated in swine that low ESS pro-
moted the initiation and progression of plaques. This was
supported by the Prediction of Progression of Coronary Ar-
tery Disease and Clinical Outcome Using Vascular Proﬁling
of Shear Stress and Wall Morphology study, demonstrating
that high ESS coronary segments underwent the largest
Figure 5. Radiofrequency IVUS cross-sectional images from 2 patients (above, moderate continuous training; below, aerobic interval training) at baseline and
follow-up illustrating transformation into less vulnerable lesions. Separate lesions underwent transformation from a thin-capped ﬁbroatheroma (above, left) to a
ﬁbroatheroma (above, right) and from a thin-capped ﬁbroatheroma (below, left) to intimal medial thickening (below, right). Green ¼ ﬁbrous tissue; green-
yellowish ¼ ﬁbro-fatty tissue; red ¼ necrotic core; and white ¼ dense calcium.
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reduction in plaque burden.24 In contrast, high ESS segments
developed greater necrotic core and excessive expansive
remodeling, suggestive of increased vulnerability, in a study
by Samady et al,6 using computational ﬂuid dynamics.
In the present study, we hypothesized that regular aerobic
exercise would induce a general increase in coronary artery
ESS and possibly more so in patients who underwent AIT.
Both groups in our study demonstrated improved physical
capacity at follow-up indicating a signiﬁcant effect from ex-
ercise that theoretically could inﬂuence plaque composition
through increased ESS irrespective of exercise group. The
ﬁnding of reduced necrotic core in our study is, therefore, in
contrast to the data from Samady et al.6 Even though a general
boost of increased ESS during exercise can be anticipated, the
inﬂuence of exercise on coronary plaques could differ sub-
stantially between coronary segments. We observed that
plaque transformation differed between separate lesions in
different coronary segments within the same patients
(Figure 4) supporting that both universal and local factors,
such as intersegment differences in ESS, may be involved in
changes of plaque characteristics.23 It is also possible that the
mechanisms for the necrotic core reduction as demonstrated
in our study could be other than increased ESS.
The Providing Regional Observations to Study Predictors
of Events in the Coronary Tree study demonstrated that
nonculprit lesions being responsible for unanticipated cor-
onary events were characterized by a large plaque burden
and TCFAs.25 We observed that most separate lesions either
did not change vulnerability or were transformed to a less
vulnerable lesion at follow-up (Figures 3 to 5). Although our
ﬁndings must be interpreted with caution, they support that
aerobic exercise combined with optimal medical treatment
has a beneﬁcial effect on plaque vulnerability. Whether
aerobic exercise, through plaque modiﬁcation, translates
into reduced risk of coronary events needs to be explored.
One study patient had a cerebral hemorrhage 36 hours
after completion of an AIT session. Although this event is not
enough to estimate risk, and the time span renders increased
blood pressure from exercise, an unlikely cause, vigorous
exercise has been identiﬁed as a trigger for rupture of intra-
cranial aneurysms.26 However, physical activity in general is
associated with decreased risk of cerebrovascular disease.27
Our study has a limited sample size. However, the study
design with interventional procedures as part of the protocol
means obvious limitations and the number of patients
included is higher than in several other exercise studies. Also,
there was some imbalance in statin use between groups at
baseline. It could be argued that this has confounded our
results, both with respect to potential group differences and
the mechanism for the antiatherogenic effects observed.
However, there were no differences in the reduction of
necrotic core or plaque burden between different statin users
with or without inclusion of exercise group afﬁliation.
Furthermore, low-density lipoprotein cholesterol and
C-reactive protein levels were essentially unchanged at
follow-up, indicating a modest statin effect during the study
period. In the Reversal of Atherosclerosis with Aggressive
Lipid Lowering trial, no atheroma regression was observed
after 2 different statin regimens administered for
18 months.28 We, therefore, argue that the reduction of
plaque burden and necrotic core observed in our trial could be
exercise induced. Strengths of our study include the use of an
independent and blinded core laboratory and well validated,
supervised exercise protocols13e15 that do not compromise
recommendations in guidelines or patient safety.29
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